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Ischemic stroke induced by obstructed blood flow to the brain accounts for the majority of all strokes. 
Although diminished blood supply to the brain results in cell death, it promotes two phases of 
cerebrovascular remodeling, which are arteriogenesis and angiogenesis. Arteriogenesis is a process that 
improving collateral circulation for blood supply, while angiogenesis is a process that sprouting new 
capillaries for oxygen and nutrients supply. Through both cerebrovascular remodeling phases, brain 
macro- and microvascular remodeling occur. Appropriate macro- and microvascular remodeling after 
ischemic stroke have been shown to correlate with improved clinical outcomes and recovery. 
Consequently, simultaneous assessment of macro- and microvascular remodeling after ischemic stroke 
is a crucial process to evaluate the status of ischemic stroke. However, a non-invasive method for 
simultaneously assess the temporally heterogenous macro- and microvascular remodeling is not well 
established.  
Ischemic stroke induced cerebral edema can be classified into several types including cytotoxic 
edema and vasogenic edema. Cytotoxic edema results in swelling of cells, which shows decreased 
magnetic resonance (MR) apparent diffusion coefficient (ADC), while vasogenic edema results in 
swelling of extracellular space, which shows increased ADC . Typically, pseudo-normalization of ADC 
occurs around a week after ischemic stroke (subacute phase). However, affected by accelerated 
development of vasogenic edema, the temporal occurrence of this pseudo-normalization of ADC could 
be spatially heterogeneous in ischemic edema lesions. The rapid development of vasogenic edema 
results in pseudo-normalization of ADC before a week after ischemic stroke. Lesions of ADC early 
pseudo-normalization showed more widespread and faster expansion into the chronic stage. As 
ischemic stroke triggers vascular remodeling, quantitative analysis of vascular remodeling difference 
between early pseudo-normalization and typical pseudo-normalization lesions can provide further 
diagnostic and prognostic information about ischemic stroke. 
To directly visualize vessels, magnetic resonance angiography (MRA) is widely used in clinical and 
scientific fields with various imaging techniques. Among techniques, contrast agent aid contrast-
enhanced (CE) MRA has intrinsically high signal-to-noise ratio, spatial resolution, and less sensitivity 
to blood flow compared to non-contrast MRA techniques, which are based on blood flow. However, the 
spatial resolution of MRA (approximately in-plane resolutions of 250 μ𝑚2 for clinical MR scanner and 
50 μ𝑚2 for small animal MR scanner) limits direct visualization of the microvasculature. However, 
administration of blood-pool contrast agent enables morphological (size and density) and functional 
(blood flow and mean transit time) mapping of microvasculature. Measurement of alteration of 
transverse relaxation rates (∆R2 and ∆R2*) due to the administration of contrast agent can generate maps 
2 
 
of morphological information of microvasculature including vessel size index (VSI) and microvessel 
density (Q and MVD), while ∆R2* contrast-based dynamic susceptibility contrast (DSC)-MRI enables 
mapping of functional information of microvasculature including relative cerebral blood flow (rCBF) 
and mean transit time (rMTT).  
In this thesis, firstly, the feasibility of dual contrast MRI for visualization of whole brain macro- and 
microvascular remodeling was verified by applying dual contrast MRI to transient middle cerebral 
artery occlusion (tMCAO) rat model. Using superparamagnetic iron oxide nanoparticles (SPION) as a 
blood-pool single contrast agent, macrovascular remodeling after ischemic stroke was longitudinally 
visualized using T1 contrast-based ultra-short echo time (UTE) MRA, while morphological 
microvascular remodeling was visualized by mapping of ∆ R2 and ∆ R2* contrast-based VSI, Q, and 
MVD. Monte Carlo simulation was performed to verify the feasibility of VSI, Q, and MVD at the MRI 
experimental conditions. Dual contrast MRI directly visualized ischemic stroke induced macrovascular 
remodeling occurs at the brain surface region from UTE-MRA. Also, the morphological microvascular 
remodeling that occurs at the brain inner region was simultaneously visualized by mapping of VSI, Q, 
and MVD.   
Secondly, morphological and functional vascular remodeling were investigated in two 
spatiotemporally different ischemic edema lesions, which are early pseudo-normalization and typical 
pseudo-normalization lesions. Macrovascular remodeling, morphological (size and density) 
microvascular remodeling, and functional (blood flow and mean transit time) microvascular remodeling 
were simultaneously visualized by UTE-MRA, VSI, MVD, and rCBF, and rMTT, respectively. 
Longitudinal acquisition of dual contrast MRI verified the quantitative difference of macrovascular 
remodeling, morphological microvascular remodeling, and functional microvascular remodeling 
between the early pseudo-normalization and typical pseudo-normalization lesions. Also, light sheet 
fluorescence microscopy (LSFM) images validated the quantitative difference of MRI-derived 
microvascular remodeling between early pseudo-normalization and typical pseudo-normalization 
lesions.   
In conclusion, ischemic stroke induced whole brain macro- and microvascular remodeling were 
investigated using dual contrast MRI. Using SPION as a single contrast agent, various vascular 
parameters were visualized and quantified. Also, the difference in vascular remodeling between early 
pseudo-normalization and typical pseudo-normalization lesions was investigated. Simultaneous 
visualization and quantification of whole brain macro- and microvascular remodeling by dual contrast 
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Chapter 1. Introduction 
1.1 Purpose 
The aim and content of this thesis can be summarized into two distinct subjects. One is to verify the 
feasibility of dual contrast MRI method for visualization of morphological macro- and microvascular 
remodeling after ischemic stroke using single superparamagnetic iron oxide nanoparticles (SPION) 
contrast agent. The other is to assess morphological and functional vascular remodeling differences 
between two heterogeneous edema lesions utilizing dual contrast MRI.  
The detailed objectives of the research are as follows: 
1) MRI visualization of whole brain macro- and microvascular remodeling in ischemic stroke rats  
2) MRI investigation of vascular remodeling for heterogeneous edema lesions in subacute 
ischemic stroke rats    
1.2 Outline 
This thesis is organized as follows: 
Chapter 2 introduces the background of this thesis. In this section, to understand the fundamental 
concept, detailed dual contrast MRI is explained including 3D ultra-short echo time magnetic resonance 
angiography (UTE-MRA),  ∆ R2- ∆ R2*-MRI, and DSC-MRI for morphological macrovascular 
remodeling, morphological microvascular remodeling, and functional microvascular remodeling, 
respectively.  
Chapter 3 describes the feasibility of dual contrast MRI for visualization of morphological macro- 
and microvascular remodeling in a transient middle cerebral artery occlusion (tMCAO) rat model. In 
ischemic edema lesions measured by apparent diffusion coefficient (ADC), macro- and microvascular 
remodeling are visualized and quantified.  
Chapter 4 describes quantitative assessment of morphological and functional vascular remodeling 
differences between two heterogeneous edema lesions by application of dual contrast MRI. Not only 
edema lesion status via ADC and T2, but also various vascular parameters are observed and quantitively 
analyzed. Also, correlation between morphological microvascular remodeling and functional 
microvascular remodeling is verified.   





ADC       Apparent diffusion coefficient 
BVf        Blood volume fraction 
CBF                 Cerebral blood flow 
CBV                 Cerebral blood volume 
CE                   Contrast enhanced 
cRHV          caudal rhinal vein 
DCV               Dorsal cerebral vein 
DLS                Differential light scattering 
DSC-MRI     Dynamic susceptibility contrast – magnetic resonance imaging 
EPI                  Echo planar imaging        
FA                    Flip angle    
FOV                Field of view 
FPM               Finite perturber method 
GRE               Gradient echo 
IACUC          Institutional animal care and use committee 
KESM            Knife-edge scanning microscopy 
LSFM            Light sheet fluorescence microscopy 
MC                  Monte carlo 
MCA               Middle cerebral artery 
MEGE           Multi echo gradient echo 
MIP                 Maximum intensity projection 
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MRA               Magnetic resonance angiography 
MRI                Magnetic resonance imaging 
MSME           Multi slice multi echo 
MTT               Mean transit time 
MVD              Microvessel density 
NA                   Number of averages 
NR                   Number of repetitions 
ROI                 Region of interest 
SE                    Spin echo 
SNR               Signal to noise ratio 
SPION           Superparamagnetic iron oxide nanoparticles 
TE                   Echo time 
tMCAO         transient middle cerebral artery 
TR                   Repetition time 
UTE                Ultra-short echo time 











Chapter 2. Background 
2.1 MRI basic contrasts 
As a non-invasive medical imaging technique, magnetic resonance imaging (MRI) is widely used 
to explore the anatomy and physiology of whole body with high sensitivity and flexibility in clinical 
and scientific fields. Unlike x-ray and computed tomography (CT), MRI scanning does not result in 
exposure to ionizing radiation. Fundamentals of MRI can be understandable as interaction between 
applied magnetic field and a nucleus that possesses spin. Atomic nuclei possessing odd number of 
protons or neutrons have a non-zero spin. intensity of magnetic resonance (MR) signal is proportional 
to gyromagnetic ratio, which is a nucleus depended constant. Single proton hydrogen (1H) is by far the 
most studied due to its abundance in human body. Other nuclei with an odd number of protons or 
neutrons such as carbon (13C), sodium (23Na), oxygen (17O), and nitrogen (15N) can be used for MRI as 
well. However, there are limitations of relatively low abundance or small gyromagnetic ratio compared 
to hydrogen (1H).  
 
Figure 2.1.1 The spin behavior in absence and presence of external magnetic field. (A) Randomly 
oriented spin vectors with absence of external magnetic field (B0). (B) Parallel alignment of spin vectors 
with presence of external magnetic field (B0). (C) Formation of net magnetization (gray arrow in z axis) 
with parallel and same direction of external magnetic field (B0). 
The net magnetization vector from numerous spins is exclusively used to explain MRI signal 
behavior. Without an external magnetic field, each spin vector orients randomly. On the contrary, with 
presence of an external magnetic field B0, spins will be aligned to parallel direction to B0 with two 
directions (positive and negative to B0 direction). But, there are slightly more positive spins that make 
non-zero net magnetization with parallel and same direction to the B0. The depiction of spin behavior 
in absence and presence of B0 is shown in Figure 2.1.1. In equilibrium state, net transverse (x-y plane) 
magnetization is zero. Generally, z-axis is the direction B0. The main signal source of MRI is net 




Figure 2.1.2 The interaction between the net magnetization and the RF magnetic field. 
To generate MR signal, oscillating magnetic field with resonance frequency of spin is required in 
addition to magnetic field B0. As resonance frequency of spin is in the range of radio frequency (RF), 
the oscillating magnetic field (B1) is induced from RF pulse. Amplitude of generated B1 field is weaker 
than B0 field. Application of the RF pulse from transmit coil with short duration (~ ms) tip down the net 
magnetization into the x-y plane to form transverse magnetization. The duration and amplitude of RF 
pulse determine a flip angle of net magnetization. Figure 2.1.2 describes the interaction between the net 
magnetization and the RF pulse.    
Figure 2.1.3 The process that transverse magnetization back to an equilibrium state (T1 relaxation). 
After formation of the transverse magnetization from RF pulse, the transverse magnetization goes 
back to its equilibrium state (z-axis). This process is called the longitudinal (T1) relaxation or spin-
lattice relaxation. The name of spin-lattice relaxation is derived from that spin gives energy back to the 
surrounding lattice. The T1 relaxation depends on energy exchange between spin and its lattice.  
Simultaneously, there is a transverse (T2) relaxation or spin-spin relaxation induced from the reducing 
transverse magnetization. The name of spin-spin relaxation is derived from that each spin affect 
neighbor spins. The interaction of spins randomly changes local magnetic fields. This process result in 
loss of phase coherence and gradually reduce the transverse magnetization. The T1 is defined as a 
relaxation time when 63% of longitudinal (z-axis) magnetization recovers its equilibrium state and the 
T2 is a relaxation time when transverse magnetization is reduced to 37% of its initial transverse 
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magnetization. The T1 relaxation is always longer than the T2 relaxation. Through Figure 2.1.3 and 
Figure 2.1.4, T1 and T2 relaxation processes are described, respectively.  
Figure 2.1.4 The process of transverse magnetization reduction (T2 relaxation). 
As a transverse relaxation, there is a T2* relaxation in addition to T2 relaxation. The T2* relaxation 
has additional transverse magnetization decaying factor which is T2’ relaxation and described as 
following equation:  
1
T2
∗ =  
1
T2
 +  
1
T2
’   (2.1.1) 
In contrast to irreversible T2 relaxation, T2’ relaxation is from a static magnetic field inhomogeneity 
resulted from magnetic susceptibility differences and is reversible. The spin echo (SE) based pulse 
sequence uses additional RF pulse as refocusing pulse to recover signal decay from the T2’ relaxation. 
However, the T2’ relaxation provides essential information regarding magnetic susceptibility. To 
manipulate the T2* relaxation, gradient echo (GRE) based pulse sequences are generally used. The GRE 
based pulse sequence uses bipolar magnetic field gradient. One direction of magnetic field gradient is 
applied as dephasing gradient to accelerate loss of spin coherence by changing local magnetic fields. 
Subsequently, the opposite direction of magnetic field gradient is applied as rephrasing gradient to 
reverse spin incoherence induced from previous dephasing gradient. Generally, the Bloch equation is 
used to express the MR signal of SE as following:  






)   (2.1.2) 
Where Mo is a proton density, T1 and T2 are relaxation time, TR is a repetition time, and TE is an 
echo time. For MR signal of GRE, modified Bloch equation is used due to the flip angle (FA) α, which 
affect T1 relaxation effect and expressed as following: 












∗)   (2.1.3) 
The M0, T1, and T2 (or T2*) are inherent constant and different depending on tissue type. The TR and 
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TE are adjustable MR parameters and they determine the weights of M0, T1, T2 and (or T2*) for various 
MR image contrasts. For example, long TE allows distinguishing relative differences of signal decay 
among various tissues. It enhances the T2 or T2* effect. On the contrary, short TE minimizes the T2 or 
T2* effect. For long TR, all transverse magnetizations from various tissues have time to back to their 
equilibrium state, which makes no significant signal difference. It minimizes the T1 effect. On the 
contrary, short TR enhances the T1 effect. Consequently, short TR and TE can generate T1-weighted 
image, while long TR and TE can generate T2-weighted or T2*-weighted images. In case of long TR and 
short TE, proton density weighted image can be acquired.   
   
2.2 3D UTE-MRA (morphology of macrovasculature) 
Generally, the MRA technique has been utilized to assess various vascular information. Over many 
decades, various MRA techniques have been developed and implemented in clinical and scientific fields. 
Among MRA techniques, contrast enhanced MRA (CE-MRA) is a technique acquired with the aid of 
contrast agent [1]. Contrast agent shortens relaxation times (T1, T2, and T2*) and offers additional 










= r2 ∙ C +
1
T2t
   (2.2.1) 
Where r1 and r2 (or r2*) are relaxivities of contrast agent and they are depending on several factors 
including magnetic field strength and temperature. The C is concentration of contrast agent and the T1t 
and T2t (or T2t*) represent intrinsic tissue T1 and T2 (or T2*) properties. Other non-contrast MRA 
techniques that do not use any contrast agent, typically rely on the blood flow to visualize vasculature 
[5]. These techniques are extensively implemented in clinical field because they do not require any 
contrast agent. However, non-contrast MRA techniques are affected mainly by artery due to their fast 
blood flow compared to veins. To visualize veins, blood oxygen level-dependent (BOLD) effect induced 
by alterations of paramagnetic deoxyhemoglobin in blood vessels has been utilized as non-contrast 
MRA [6,7]. In contrast to non-contrast MRA, the CE-MRA can simultaneously visualize arteries and 
veins. Commonly, T1 contrast enhanced MRA with gadolinium (Gd) based contrast agent is acquired 
[8-10]. After administration of Gd-based contrast agent, T1 of blood is reduced and result in 
improvement of the vessel-tissue contrast. Superparamagnetic iron oxide nanoparticles (SPION) 
contrast agent can be utilized as T1 contrast enhanced MRA as well. As SPION has characteristics of 
adequate size, high relaxivities and relatively long plasma half-life, it is utilized as blood pool contrast 
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agent. Most blood pool contrast agents have high molecular weight, which prevent them leaking from 
vessel to interstitial space.   
Ultra-short echo time (UTE) is MRI pulse sequence that utilized to image tissue components having 
short T2 with an extremely short TE [11]. The implementation of 3D allows much reduced TE compared 
to 2D due to non-selective RF excitation. The UTE pulse sequence radially samples k-space, which is 
a grid of raw data acquired directly from the MR signals. After a hard RF pulse for non-selective RF 
excitation, echoes are immediately collected to the k-space with center-out and half-radial sampling by 
all three directions of imaging gradients. The center-out and half-radial sampling of 3D UTE offers the 
shortest executable TE and insensitivity to motion and flow artifacts because it inherently compensates 
the flow [12]. Figure 2.2.1 shows k-spaces with radial sampling and conventional cartesian sampling. 
The radial sampling method inherently performs oversampling the center of k-space. This overlapping 
can be utilized for motion detection and correction. The radial sampling results in high sampling density 
in center k-space and low sampling density in outer k-space. The drawback of radial sampling is that 
non-uniformly sampled k-space should be gridded to form a cartesian grid before image formation and 







Figure 2.2.1 K-spaces with radial sampling (left) and cartesian sampling (right). 
 
2.3 ∆R2-∆R2*-MRI (morphology of microvasculature) 
Although MRA technique offers direct visualization of vasculature, the spatial resolution limitation 
of MRI hamper its application to assess microvasculature. Characterization of microvasculature could 
provide information about diseases. However, analytical approaches verified feasibility that utilizing 
alteration of transverse relaxation rates (∆ R2 and ∆ R2*), which are induced from administration of 
contrast agent, can visualize morphology of microvasculature such as vessel size and density [13]. Both 
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dynamic and steady-state acquisition methods can acquire SE based ∆R2 and gradient echo based ∆R2*. 
The dynamic acquisition method allows faster acquisition of  ∆ R2 and  ∆ R2* at the expense of the 
coverage and spatial resolution. On the contrary, compared to the dynamic acquisition method, the 
steady-state acquisition method offers high spatial resolution and large coverage at the expense of scan 
time. For the morphology of microvasculature, vessel size index (VSI) and vessel density (Q and MVD) 
can be acquired by following equations [13,14]: 
VSI (μm) = 0.424(ADC/(γ∆χB0))1/2(∆R2*/∆R2)3/2  (2.3.1) 
Q (s-1/3) = ∆R2/(∆R2*)2/3  (2.3.2) 
MVD (mm-2) ≈ Q3/(4.725ADC)  (2.3.3) 
Where γ is the gyromagnetic ratio and B0 is the strength of main magnetic field. Apparent diffusion 
coefficient (ADC) is the term reflecting magnitude of diffusion within tissue. The ADC is measured by 
diffusion weighted imaging (DWI) technique of MRI. The  ∆χ  is the intravascular susceptibility 
difference due to the administration of contrast agent. The ∆χ depends on the concentration of contrast 




4π BVf γ B0 
   (2.3.4) 
The BVf is the blood volume fraction. Since the introduction of the VSI, Q, and MVD, they have 
been successfully implemented to assess microvascular size and density in clinical and scientific fields. 
Also, other validation studies verified quantitative consistency of MRI-derived VSI, Q, and MVD.  
 
2.4 DSC-MRI (function of microvasculature) 
Utilizing diverse MRI techniques, not only morphological information but also functional 
information about microvasculature can be acquired. For functional microvascular information, 
perfusion MRI techniques are generally used. As a perfusion MRI technique, dynamic susceptibility 
contrast MRI (DSC-MRI) provides hemodynamic parameters, which are cerebral blood volume (CBV), 
cerebral blood flow (CBF), and mean transit time (MTT) [15-17]. A susceptibility from contrast agent 
passing through capillary network results in regional signal loss, which DSC-MRI technique exploits. 
For the DSC-MRI technique, both T2 and T2* MR sequences can be used. However, T2-based DSC-MRI 
requires higher dose of contrast agent compared to T2*-based DSC-MRI. Consequently, using GRE 
echo-planar imaging (EPI) pulse sequence, T2*-based DSC-MRI is generally employed [18].  
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For detection of signal loss, rapidly repeated images of the tissue are acquired during intravenous 
bolus administration of contrast agent. The susceptibility-induced signal loss is primarily affected by 
amount of the contrast material primarily in the microvasculature [18,19]. Measured time-series signal 








)   (2.4.1) 
Where Spre is an averaged signal before the administration of contrast agent. During the first passage 
of contrast agent, time-series signal alteration induced  ∆ R2* curve should be acquired. However, 
affected by recirculation, mixed curve is measured as shown in Figure 2.4.1. To eliminate contribution 
of recirculation, the ∆R2* curve is commonly fitted with gamma-variate function [21,22]: 
ΔR2
∗(t) = Ktα exp(−βt)   (2.4.2) 
Where K, α, and β are constant and arbitrary parameters, respectively. Subsequently, perfusion 
parameters which are relative CBV (rCBV), MTT, and relative (rCBF) can be acquired with the 
following equations [15,22]: 



















The rCBV can be acquired by measuring area under ∆R2* curve, while the MTT can be acquired by 
using the non-deconvolved ∆R2* curve. By dividing previously acquired rCBV and MTT, the rCBF can 









Figure 2.4.1 DSC-MRI signal intensity curve.   
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Chapter 3. Dual contrast MRI: Method 
3.1 Introduction 
Obstruction of the blood supply to part of the brain causes an ischemic stroke. Although diminished 
blood flow can result in cell death, it typically promotes two-phase cerebrovascular remodeling 
involving arteriogenesis and angiogenesis. Arteriogenesis, induced by physical forces such as fluid 
shear stress and circumferential wall stress, is a process that improves collateral circulation by 
vasodilating pre-existing circulatory anastomoses [23]. Vasodilation lasts until the physical forces are 
normalized [24]. Then, the dilated vessels are known to return to their normal diameter [25]. However, 
the remodeling of venous vessel size and its association with ischemic edema status is rarely 
investigated in the post-ischemic brain. Angiogenesis is triggered by hypoxia and induces pro-
angiogenic factors that result in the sprouting of new capillaries from pre-existing vessels for 
maintenance or restoration of local oxygen and nutrition supplies [23,26]. In general, arteriogenesis is 
involved in both macro- and microvascular remodeling, while angiogenesis is a mechanism of 
microvascular remodeling. Adequate collateral circulation status through arteriogenesis and increased 
microvessel density through angiogenesis have been shown to correlate with better clinical outcomes 
and recovery after ischemic stroke [27-35]. However, noninvasive methods for simultaneously 
assessing morphological macro- and microvascular remodeling after ischemic stroke have not been 
established, and there is little experimental evidence of the need for such evaluation. 
As a noninvasive imaging modality, magnetic resonance imaging (MRI) can provide morphological 
information about the vascular system. With those advantages, MRI is being widely used to investigate 
vascular remodeling after ischemic stroke. Time of flight MR angiography (TOF-MRA) has revealed 
an association between arteriogenic collateral circulation and clinical outcomes [36-38]. In a preclinical 
study of transient middle cerebral artery occlusion (tMCAO) in a rat model, TOF-MRA showed that 
macrovascular remodeling occurred at the rat brain surface region [39]. However, previous TOF-MRA 
studies on the ischemic stroke brains have focused mainly on arterial blood vessels, and vascular 
remodeling of venous pial vessels has hardly been studied to our knowledge. Also, the low spatial 
resolution of MRA limits the direct local morphological visualization of microvascular remodeling [23].  
On the other hand, the spatial changes of MR signals can be measured with the administration of a 
blood-pool contrast agent, enabling morphological mapping of the macro- and microvasculature. To 
obtain morphological information regarding the entire macrovasculature, high resolution 3-dimensional 
T1-contrast-based ultra-short echo time MR angiography (UTE-MRA) can be used [40,41]. To obtain 
morphological information about the microvasculature, vessel size index (VSI) and microvessel density 
indices (Q and MVD) can be measured. VSI, Q, and MVD values obtained through alteration of 
20 
 
transverse relaxation rates (∆R2 and ∆R2*) due to the administration of contrast agent [13,42,43] can be 
used to map morphological microvascular alterations after ischemic stroke [44-50]. As arteriogenesis 
and angiogenesis are likely to correlate with recovery after ischemic stroke, the association between 
vessel morphology and corresponding tissue ischemic edema status (via apparent diffusion coefficient 
[ADC])) can be verified by simultaneous assessment of total macro- and microvascular remodeling in 
the ischemic brain.  
In this pilot study, we performed dual contrast MRI using superparamagnetic iron oxide 
nanoparticles (SPION) as a single contrast agent [40,41]. We used Monte Carlo simulation to optimize 
the dose of SPION by correlating ∆R2 and ∆R2* values at various vessel sizes/volumes at 7-T. High 
resolution (59  μ m3) 3-dimensional UTE-MRA was combined with ∆ R2- ∆ R2*-MRI derived 
VSI/Q/MVD maps on tMCAO rat models. Such dual contrast MRI acquisition enabled simultaneous 
morphological visualization of macrovascular size remodeling at the brain surface region and 
microvascular size/density remodeling at the deep inner brain region. ADC values, macrovascular 
diameters (UTE-MRA) and microvascular size /density (VSI/Q/MVD) in cortical and subcortical 
regions were respectively evaluated and compared to elucidate the morphological responses of the 
cerebral vascular system in rat brain during recovery of ischemic stroke. 
 
3.2 Materials and methods 
3.2.1 Animal preparation 
All animal experiments were approved by the Institutional Animal Care and Use Committee (IACUC) 
of the Ulsan National Institute of Science and Technology (UNIST) and carried out in accordance with 
the Animal Protection Act of Korea and Guide for the Care and Use of Laboratory Animals of the 
National Institutes of Health. Adult male Wistar rats (body weight 280-320 g) were housed in cages 
under a 12 h light/12 h dark cycle with ad libitum access to food and water. Rats were initially 
anesthetized by inhalation of 3% isoflurane in a mixture of 30% oxygen and 70% nitrous oxide and 
isoflurane was maintained in the range of 1~1.5% during surgery and MRI acquisition. As isoflurane 
and nitrous oxide is known to involve some degree of vessel dilations, vasculatures in contralateral 
brains were used as a reference to monitor any ipsilateral vascular alterations. Body temperature was 
kept constant (37 ± 1 ℃) by using a warm-water circuit integrated into the animal bed and a feedback-
controlled heating pad for MRI acquisition and surgery, respectively. Focal brain ischemia was induced 
by transient occlusion of the middle cerebral artery (MCA) according to a previously described method 
[51,52] with an intraluminal monofilament (0.37 mm diameter filament, Doccol Corporation, Redlands, 
CA, USA). After 60 min of occlusion, the filament was withdrawn and the wound was sutured under 
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local anesthesia. MRI acquisitions were performed on the tMCAO rats up to reperfusion day 7 after 
surgery. 
 
3.2.2 Microvessel size and density simulation 
Monte Carlo simulation was performed to optimize the dose of SPION and examine the feasibility of 
vessel size-related VSI and microvessel density-related Q and MVD by comparing them with input 
vascular size and vascular density in experimental MRI parameters, similar to the methods used in a 
previous study [13]. The simulation was implemented via in-house MATLAB (MathWorks, Natick, 
MA) scripts, which are based on the finite perturber method (FPM) [53] and analogous to previously 
described procedures [41,54,55]. Randomly oriented cylinders were generated in a 3-dimensional 
binary matrix (400 × 400 × 400) to represent microvessels in a tissue. The magnetic field shift (∆B) 
was calculated as the sum of magnetic field shifts from all the perturbers. As simulation parameters, the 
main magnetic field (B0) was set to 7-T and the magnetic susceptibility difference between the 
intravascular contrast agent and nearby tissue (∆χ) was set to 4.5 × 10-7 (CGS unit) corresponding to 
a SPION dose of 360 μmol Fe/Kg (20.106 mg/Kg) [41,56]. The Monte Carlo simulation was performed 
consecutively for the estimation of  ∆R2 and  ∆R2* values. Initially, 64,000,000 (400  × 400  × 400) 
protons were positioned uniformly within the diffusion space. In the periodic boundary condition, each 
proton was diffused to an adjacent position in the simulation unit time (∆t) of 1 ms, with the diffusion 
length of √2D∆t (D: diffusion coefficient, 800 μm2/s). The phase accumulation of each proton during 
diffusion time induced from different magnetic field shifts according to the position of each proton was 
calculated. Subsequently,  ∆ R2 and  ∆ R2* values from the MR signal estimated by averaging the 
accumulated phase of total diffusing protons were calculated with ∆R2, ∆R2* = −
ln [S(TE)]
TE
. TEs for the 
simulation and calculation of  ∆R2 and  ∆R2* values were 8 ms and 3 ms, respectively. Based on 
simulated ∆R2 and ∆R2* values, VSI/Q/MVD values were calculated with the following equations 
[13,14,42,43]: 
VSI (μm) = 0.424(D/(γ∆χB0))1/2(∆R2*/∆R2)3/2     (1) 
Q (s-1/3) = ∆R2/(∆R2*)2/3     (2) 
MVD (mm-2) ≈ Q3/(4.725D)     (3) 
To simulate various microvascular conditions, different vascular radii (2-10 μm) were generated 
with several blood volume fractions (Bvfs) of 2%, 4%, and 6%. The MR signal simulation for each 






3.2.3 MRI acquisition 
All MRI acquisitions were carried out on a 7-T MR scanner (Bruker, Ettlingen, Germany) with a 40-
mm volume coil. Before administration of SPION, ADC, R2, and R2* maps were acquired. After 
administration of SPION, subsequent R2 and R2* maps were sequentially acquired to generate ∆R2 
and ∆R2* maps. Lastly, UTE-MRA was acquired after the measurement of ∆R2 and ∆R2*. SPION was 
synthesized in house18. The core size distribution of the iron oxide was 5 to 10 nm. Based on differential 
light scattering (DLS) experiment, the mean hydrodynamic diameter of the iron oxide nanoparticles 
was 20 ± 7 nm. The r1 and r2 of SPION were 2.36 mM-1s-1 and 32.94 mM-1s-1 at 7-T. SPION was 
administered as an intravenous bolus with a dose of 360 μmol Fe/Kg (optimized dose from simulation). 
For the experimental validations, two normal rats were scanned before and after SPION administration 
for UTE-MRA and two tMCAO rats were studied at 1 day after reperfusion for ∆R2-∆R2*-MRI. Then, 
four tMCAO rats were studied at 1, 4, and 7 days after reperfusion for the quantification of macro- or 
microvascular remodeling with corresponding ADC measurements. 
The ADC map was acquired using a diffusion-weighted echo planar imaging (EPI) pulse sequence 
with the following parameters: TR/TE = 3500/25.2 ms; number of averages (NA) = 8; number of 
segments = 3; b-values = 100, 200, 400, 600, 800, and 1000 s∙mm-2; flip angle (FA) = 90 °; matrix size 
= 100 × 100; field of view (FOV) = 30 × 30 mm2; resolution = 300 × 300 μm2; number of slices = 8; 
slice thickness = 1 mm.  
The ∆R2 map was acquired using a multi-slice multi-echo (MSME) pulse sequence with the 
following parameters: TR = 6000 ms; TE = 8-160 ms; echo spacing = 8 ms; NA =1; FA = 90 °; matrix 
size = 256 × 256; FOV = 30 × 30 mm2; resolution = 117 × 117 μm2; number of slices = 8; slice 
thickness = 1 mm. 
The ∆R2* map was acquired using a multi-echo gradient echo (MEGE) pulse sequence with the 
following parameters: TR = 6000 ms; TE = 3-59 ms; echo spacing = 4 ms; NA = 1; FA = 90 °; matrix 
size = 256 × 256; FOV = 30 × 30 mm2; resolution = 117 × 117 μm2; number of slices = 8; slice 
thickness = 1 mm. 
The UTE-MRA was acquired using an ultra-short echo time (UTE) pulse sequence with the 
following parameters: TR/TE = 22/0.012 ms; NA = 1; FA = 40 °; under-sampling factor = 1.13; matrix 
size = 512 × 512 × 512; FOV = 30 × 30 × 30 mm3; resolution = 59 × 59 × 59 μm3.  
 
3.2.4 Data processing and analysis 
Data processing and analysis were performed with MATLAB, RStudio (RStudio, Boston, MA), and 
ImageJ (US National Institutes of Health, Bethesda, MD) software. Voxel-wise ADC values were 
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obtained by fitting the mono-exponential decay equation S = S0×exp(-ADC×b-value) with a nonlinear 
least-squares-fitting method.  
The ∆R2 and ∆R2* values were calculated by subtracting the transverse relaxation rates (R2 and R2*) 
values acquired before administration of SPION from the R2 and R2* values acquired after 
administration of SPION. Voxel-wise R2 and R2* values were obtained by fitting the mono-exponential 
decay equation S = S0×exp(-TE×[R2 or R2*]). ∆R2 and ∆R2* maps were used to determine VSI, Q, and 
MVD maps following equations (1), (2), and (3). 
 
Figure 3.1 Original and BM4D filter applied UTE-MRAs. Dorsal views (A and C) and anterior-to-
posterior views (B and D) of normal rat brain UTE-MRA and BM4D filter applied UTE-MRA with 60-
slices maximum intensity projection and application of the same threshold value, respectively. SNR 
values of 3.8828 and 19.6091 for UTE-MRA and BM4D filter applied UTE-MRA, respectively. 
Acquired UTE-MRAs were denoised by application of a BM4D filter [57]. Improved signal-to-
noise ratio (SNR) in BM4D filter applied UTE-MRA is shown in Figure 3.1. The brain region of each 
UTE-MRA was segmented using a rat brain atlas [58] for visualization of brain vasculature only. 
Volume rendered UTE-MRAs were thresholded and visualized by 3DSlicer software (www.slicer.org) 
for the investigation of macrovascular remodeling in tMCAO rat models. The boundary value between 
noise and signal was set as a threshold value to delineate vasculature. In the accompanying figures, 
UTE-MRAs with the bluish and the yellowish regions represent brain tissue and brain vasculature, 
respectively. For the acquisition of vascular diameters from UTE-MRA, vasculatures in the UTE-MRA 
were segmented and thresholded. The same threshold value was set for each tMCAO rat model to reduce 
bias from diameter calculation. Based on binary images, the vascular diameters were calculated by 
fitting maximal spheres to every point in the vascular structure [59] via BoneJ software [60]. The 
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average diameter of the fitted sphere in the main vascular branch was determined as the corresponding 
vessel diameter. Also, the standard deviation was calculated to represent the error bar.     
 
 






Figure 3.2 Scheme for cortex and subcortex segmentation. Representative ROIs for cortical and 
subcortical ischemic edema regions in ipsilateral hemisphere and corresponding normal regions in the 
contralateral hemisphere (A). Representative ROIs for subcortical ischemic edema region in ipsilateral 
hemisphere and corresponding normal region in contralateral hemisphere (B). A green line indicates 
ROI of cortical ischemic edema region in ipsilateral hemisphere, a red line indicates ROI of 
corresponding cortical normal region in contralateral hemisphere, purple lines indicate ROIs of 
subcortical ischemic edema regions in ipsilateral hemispheres, and black lines indicate ROIs of 
corresponding subcortical normal regions in contralateral hemisphere. 
Cortical and subcortical regions of the ipsilateral and contralateral hemispheres were selected and 
segmented from the ADC map (4 or 5 slices to cover whole brain ischemic edema) of each experiment 
as shown in Figure 3.2. The values of ADC, VSI, Q, and MVD in the corresponding area were calculated 
and evaluated. Subsequently, relationship between the ADC value of the cerebral cortex and the pial 
venous (cRHV and DCV) and arterial (MCA) vessel diameters (derived from UTE-MRA) were shown 
using a bar graph for ischemic edema (ADCmean < 650 μm2/s) and normal tissue (ADCmean > 650 μm2/s), 
respectively. Correspondingly, correlation between the subcortical ADC and VSI/Q/MVD values 
(derived from ∆R2-∆R2*-MRI) were shown using a double box plot for ischemic edema and normal 
tissue, respectively. Conclusively with combined data from all experiments, Student’s t-tests were 
performed to assess the significant differences of MR-derived vascular morphological parameters 
between the ischemic edema and normal tissue. As a validation study of MR-derived VSI, 3-
dimensional mouse brain microvascular data from the (knife-edge scanning microscope) KESM brain 
atlas (http://kesm.cs.tamu.edu/home/index.php) was used [61,62]. The vasculature was selected by 






3.3.1 High-resolution UTE-MRA  
Figure 3.3 shows two normal volume-rendered rat brains acquired from high-resolution UTE-MRAs. 
Before administration of SPION, no cerebral veins are visible in the dorsal view (Figure 3.3(A)). In 
contrast, major arteries composing and contributing to the circle of Willis are visible in the ventral view 
(Figure 3.3(B), red arrows). In lateral views (Figure 3.3(C), red arrow), ascending MCAs are visible. 
No vessels are visible in the anterior-to-posterior view (Figure 3.3(D)). UTE-MRA before 
administration of SPION is a TOF-MRA, which shows large arteries populating the brain surface region. 
After administration of SPION, not only major arteries but also veins (including DCV, IPTGV, and 
cRHV) are visible in the dorsal (Figure 3.3(E), red arrow), ventral (Figure 3.3(F), red arrow), and lateral 
views (Figure 3.3(G), red arrows). In the anterior-to-posterior view (Figure 3.3(H)), intracortical 
penetrating and other macro-vessels are shown. 
Figure 3.3 UTE-MRAs of two normal rat brain. Dorsal views (A and E), ventral views (B and F), lateral 
views (C and G) and anterior-to-posterior views (D and H) of UTE-MRAs acquired before and after 
administration of SPION, respectively. Red arrows indicate middle cerebral artery (MCA), posterior 
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cerebral artery (PCA), internal carotid artery (ICA), anterior cerebral artery (ACA), superior cerebellar 
artery (SCA), vertebral artery (VA), basilar artery (BA), dorsal cerebral vein (DCV), interpterygoid 








Figure 3.4 Macrovascular remodeling of tMCAO rat brain. The results of diameter fittings of cRHV, 
DCV and MCA in ipsilateral hemisphere at reperfusion day 4 (A) and at reperfusion day 7 (B). 
Corresponding snapshot of cRHV at reperfusion day 7 (C). The mean value of fitted sphere diameters 
of the main branch was set as respective vessel diameter. Vessel diameters of cRHV (orange), DCV 
(blue), and MCA (purple) of the ipsilateral hemisphere with respect to mean ADC values of the 
corresponding cortical lesion at reperfusion days 4 and 7 (D). Vessel diameters of cRHV (orange), DCV 
(blue), and MCA (purple) of the contralateral hemisphere with respect to mean ADC values of the 
corresponding cortical region at reperfusion days 4 and 7 (E). The dotted vertical lines mark the ADC 
= 650 μm2/s, which are set to separate ischemic edema from recovered/normal tissue. 
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To directly visualize alterations of macrovasculature in ipsilateral hemisphere of UTE-MRAs, 
vessel diameter maps of cRHV, DCV and MCA in the ipsilateral hemisphere at reperfusion day 4 and 
day 7 are shown in Figures 3.4(A) and (B). As the illustrations for morphological changes of 
macrovasculature in the tMCAO model, longitudinally acquired UTE-MRAs and ADC maps of re-
perfused tMCAO rat brains are fully shown in Figure 3.5. Bar graphs show mean ADC values of cortical 
regions along with the diameters of cRHV, DCV, and MCA in the ipsilateral and contralateral 
hemispheres at reperfusion day 4 (ischemic edema in the ipsilateral brain) and at reperfusion day 7 
(recovered ischemic edema in the ipsilateral brain) as shown in Figures 3.4(D) and (E), respectively. 
Only the main branches of vasculatures were used to calculate mean vessel diameter to minimize 
measurement errors. A significant dilation of the pial venous vessels in the ipsilateral region is evident 
at reperfusion day 4 and reduced to normal diameters at reperfusion day 7, followed by recovery of the 
corresponding mean ADC value as shown in Figure 3.4(D). A snapshot of the corresponding cRHV is 
shown in Figure 3.4(C) at reperfusion day 7 as a reference for direct comparison with UTE-MRA. No 
significant variations were observed for both cRHV and DCV in the contralateral brain (Figure 3.4(E)). 
As shown in Figures 3.4(D) and (E), the MCA thinned at reperfusion day 4 was restored to its normal 









Figure 3.5 Macrovascular remodeling of tMCAO rat brain. Lateral views of ipsilateral hemisphere (A, 
E, and I), anterior-to-posterior views (B, F, and J) and lateral views of contralateral hemisphere (C, G, 





Figure 3.6 Monte Carlo simulation results. Vessel radius and blood volume fraction (Bvf) dependent 
simulated ∆R2 (A) and ∆R2*(B). Comparison of simulated VSI with true vessel radius (C). Comparisons 
of simulated Q and MVD with true vessel density (D and E, respectively). Experimental VSI map (F) 
and distribution (G) in the cortical region (ROI, marked with purple line in F). Corresponding gold-
stand vessel size map (H) and distribution (I) in cortical region from knife-edge scanning microscope 
(ROI, marked with purple line in H).  
 
3.3.2 ∆R2-∆R2*-MRI  
Vessel radius and Bvf-dependent ∆R2 and ∆R2* values from the Monte Carlo simulation are shown at 
7-T with experimental SPION dose and MRI parameters in Figures 3.6(A) and (B), respectively. As 
vessel radius increased, simulated  ∆ R2 values decreased while simulated  ∆ R2* values were 
approximately constant in all Bvf conditions. Also, as Bvf increased, simulated ∆R2 and ∆R2* values 
increased in the same vessel radius condition. Simulated VSI (Figure 3.6(C)) showed insignificant 
dependency on Bvf and increased as a function of the input vessel radius. Simulated Q and MVD values 
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increased as a function of input vessel density, irrespective of Bvf (Figures 3.6(D) and (E)). 
Experimental VSI values distribution in the cortical region (ROI was shown in Figure 3.6(F)) is shown 
in Figure 3.6(G). In direct comparison, the gold-standard vessel size distribution of the cortical region 
(ROI was shown in Figure 3.6(H)) from KESM is shown in Figure 3.6(I) and shows a consistent long-
tail toward larger values distribution with respect to the experimental VSI values distribution. Median 
values of VSI and KESM are 4.06 μm and 4.03 μm, respectively. Although fitted echo trains showed 
low ∆R2 values [13], those values showed less fluctuation compared to ∆R2 values from the first echo 
(Figure 3.7). ∆R2 values (~20 s-1) from simulated (Bvf 2%, radii 2-4 μm) and the first echo of MSME 
acquisition were consistent as shown in Figure 3.7. For VSI/Q/MVD calculation, robust ∆R2 maps 
obtained from fitted echo trains were multiplied by factor of 4.375 (determined from experiments) and 












Figure 3.7 ∆R2 value calibration. Simulated ∆R2 values (A, red box) and corresponding values obtained 
from the first echo of MSME acquisition were consistent (B, red line). The ∆R2 values obtained from 
the fitted echo trains of MSME acquisition (B, blue line). The ratio between ∆R2 values first echo and 






Figure 3.8 Microvascular remodeling of two tMCAO rat brains. ADC maps (A and F), VSI maps (B 
and G), and Q maps (C and H) of two tMCAO rat brains at reperfusion day 1. Double box plots between 
VSI values and corresponding ADC values of subcortex for both rats (D and I). Double box plots 
between Q values and corresponding ADC values of subcortex for both rats (E and J). The dotted 
vertical lines mark the ADC = 650 μm2/s, which are set to separate ischemic edema from normal tissue.  
 
As the illustrations for morphological changes of microvasculature in the tMCAO model, ADC, 
VSI, and Q maps of two tMCAO rat brains acquired at early reperfusion day (day 1) are shown in Figure 
3.8. The two tMCAO rat brains show different ischemic edema size in the ipsilateral hemisphere of the 
ADC maps (Figures 3.8(A) and (F)). In each ipsilateral ischemic edema lesion, the corresponding VSI 
map showed increased VSI values than the corresponding region in the contralateral hemisphere 
(Figures 3.8(B) and (G)). In contrast, each Q map showed lower values compared to those of the 
corresponding region in the contralateral hemisphere (Figures 3.8(C) and (H)). The location of 
abnormal ADC, VSI, and Q values appeared to be strongly co-localized. Double box plots (VSI versus 
ADC and Q versus ADC) verified increased VSI values and decreased Q values in the subcortical 
ischemic edema lesions (ADCmean < 650 μm2/s) of the ipsilateral side compared with those of the 







Figure 3.9 Macro- and microvascular remodeling of tMCAO rat brain. Lateral views of ipsilateral 
hemisphere (A and I) and anterior-to-posterior views (B and J) of tMCAO rat brain UTE-MRAs and 
corresponding ADC maps (C and K), VSI maps (D and L), and Q maps (E and M) of tMCAO rat brain 
acquired at reperfusion days 4 and 7, respectively. Vessel diameters of cRHV (orange), DCV (blue), 
and MCA (purple) of the ipsilateral hemisphere with respect to mean ADC values of the corresponding 
cortical lesion at reperfusion days 4 and 7 (F). Vessel diameters of cRHV (orange), DCV (blue), and 
MCA (purple) of the contralateral hemisphere with respect to mean ADC values of the corresponding 
cortical region at reperfusion days 4 and 7 (N). Double box plots between VSI values and corresponding 
ADC values of subcortex (G and O) for reperfusion days 4 and 7, respectively. Double box plots 
between Q values and corresponding ADC values of subcortex (H and P) for reperfusion days 4 and 7, 
respectively. The dotted vertical lines mark the ADC = 650 μm2/s, which are set to separate ischemic 
edema from recovered/normal tissue. 
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3.3.3 Dual contrast MRI 
Longitudinal dual contrast MRI results, which reflected macro- and microvascular remodeling in 
tMCAO rat models, are shown in Figures 3.9, 3.10, and 3.11. Even though each tMCAO rat model 
showed heterogeneous evolution after reperfusion, distinct vascular size alterations and density 
reductions at early reperfusion days (day 1~day 4) were consistently observed in the area of ipsilateral 
ischemic edema. After such alterations, morphological normalization of the pial vessels and 
microvessels was observed to be associated with the recovery of respective ADC values in the cerebral 
cortex and subcortex at late reperfusion day (day 7). 
First, this tMCAO rat model demonstrates the necessity of whole-brain simultaneous mapping of 
the macro- and microvasculature after ischemic stroke. UTE-MRAs, ADC, VSI, and Q maps are shown 
in Figures 3.9(A), (B), (C), (D), (E), (I), (J), (K), (L), and (M). As reperfusion continued from day 4 to 
day 7, enlarged cRHV and DCV in the lateral view of ipsilateral hemisphere became thinner in UTE-
MRAs (Figures 3.9(A) and (I), red arrows). The corresponding ADC values in the cortical ischemic 
edema region increased, while those of the subcortical ischemic edema region did not significantly 
change, as shown in Figures 3.9(C) and (K). In other words, high-resolution UTE-MRAs were 
insufficient to explain the observed persistence of ischemic edema in the subcortical region. In contrast, 
increased VSI and decreased Q values in the subcortical ischemic edema region (abnormal 
microvascular remodeling) were observed, as shown in Figures 3.9(D), (E), (L), and (M); this explains 
the persistence of edema in the corresponding region. Figures 3.9(B) and (J) show brain inner regions 
of UTE-MRAs as the same slice position and thickness with VSI/Q maps. Abnormality of vessels in 
subcortical ischemic edema region is more distinctly visible in VSI/Q maps compared to brain inner 
region of UTE-MRA at reperfusion day 7 (Figures 3.9(J), (L), and (M)). 
In the cortical area, bar graphs show the diameter changes of cRHV, DCV, and MCA located in the 
ipsilateral (Figure 3.9(F)) and contralateral (Figure 3.9(N)) hemisphere at day 4 (ischemic edema 
(ADCmean < 650 μm2/s) in cortex and subcortex) and day 7 (ischemic edema in subcortex only) after 
reperfusion. The mean ADC values of each cortex are also shown. A significant dilation of pial venous 
vessels (cRHV and DCV) in the ipsilateral area is evident at reperfusion day 4, decreased to the normal 
diameter at reperfusion day 7, and corresponding mean ADC value at reperfusion day 7 was restored. 
The reduced diameter of MCA in the ipsilateral side at reperfusion day 4 was normalized at reperfusion 
day 7. In the subcortical area, double box plots show increased VSI and decreased Q values in ipsilateral 
ischemic edema lesions compared to those of in the contralateral region at both 4 and 7 days after 
reperfusion (Figures 3.9(G), (H), (O), and (P)). Thus, persisting microvascular changes were observed 
along with non-recovering ADC values in subcortical ischemic edema region regardless of normal 
macrovascular remodeling in the cortical ischemic edema region.  
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 Figure 3.10 Macro- and microvascular remodeling of tMCAO rat brain. Lateral views of ipsilateral 
hemisphere (A and I) and anterior-to-posterior views (B and J) of tMCAO rat brain UTE-MRAs and 
corresponding ADC maps (C and K), VSI maps (D and L), and Q maps (E and M) of tMCAO rat brain 
acquired at reperfusion days 1 and 7, respectively. Vessel diameters of cRHV (orange), DCV (blue), and 
MCA (purple) of the ipsilateral hemisphere with respect to mean ADC values of the corresponding 
cortical lesion at reperfusion days 1 and 7 (F). Vessel diameters of cRHV (orange), DCV (blue), and 
MCA (purple) of the contralateral hemisphere with respect to mean ADC values of the corresponding 
cortical region at reperfusion days 1 and 7 (N). Double box plots between VSI values and corresponding 
ADC values of subcortex (G and O) for reperfusion days 1 and 7, respectively. Double box plots 
between Q values and corresponding ADC values of subcortex (H and P) for reperfusion days 1 and 7, 
respectively. The dotted vertical lines mark the ADC = 650 μm2/s, which are set to separate ischemic 




Figure 3.11 Macro- and microvascular remodeling of tMCAO rat brain. Lateral views of ipsilateral 
hemisphere (A and I) and anterior-to-posterior views (B and J) of tMCAO rat brain UTE-MRAs and 
corresponding ADC maps (C and K), VSI maps (D and L), and Q maps (E and M) of tMCAO rat brain 
acquired at reperfusion days 4 and 7, respectively. Vessel diameters of cRHV (orange), DCV (blue), and 
MCA (purple) of the ipsilateral hemisphere with respect to mean ADC values of the corresponding 
cortical lesion at reperfusion days 4 and 7 (F). Vessel diameters of cRHV (orange), DCV (blue), and 
MCA (purple) of the contralateral hemisphere with respect to mean ADC values of the corresponding 
cortical region at reperfusion days 4 and 7 (N). Double box plots between VSI values and corresponding 
ADC values of subcortex (G and O) for reperfusion days 4 and 7, respectively. Double box plots 
between Q values and corresponding ADC values of subcortex (H and P) for reperfusion days 4 and 7, 
respectively. The black dotted vertical lines mark the ADC = 650 μ m2/s, which are set to separate 
ischemic edema from recovered/normal tissue. The red dotted vertical line separates recovered tissue 
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from necrotic tissue. 
Second, we show a case of normal recovery of both cortical and subcortical lesions after reperfusion 
and explain the association of morphological vascular normalizations with ADC values. UTE-MRAs 
showed normal thinning of a dilated cRHV and DCV in lateral views of the ipsilateral hemisphere as 
reperfusion continued from day 1 to day 7 (Figures 3.10(A) and (I), red arrows). Corresponding cortical 
ADC values in the ischemic edema region increased as reperfusion continued from day 1 to day 7 
(Figures 3.10(C) and (K)). Consistently, VSI values in the ischemic edema lesion decreased and Q 
values increased and returned to normal range, comparable to those of the contralateral hemisphere at 
reperfusion day 7 (Figures 3.10(D), (E), (L), and (M)). Subcortical ADC values in the ischemic edema 
region also increased to the normal range as reperfusion continued from day 1 to day 7 as well (Figures 
3.10(C) and (K)). 
In the cortical area, bar graphs show mean ADC values along with the diameters of cRHV, DCV, 
and MCA located in the ipsilateral (Figure 3.10(F)) and contralateral (Figure 3.10(N)) hemisphere at 
day 1 (ischemic edema in cortex and subcortex) and day 7 (recovered ischemic edema in ipsilateral 
brain) after reperfusion, respectively. A significant dilation of cRHV in the ipsilateral area was evident 
at reperfusion day 1, decreased to the normal diameter at reperfusion day 7, and corresponding ADC 
value at reperfusion day 7 was restored. On the other hand, DCV showed unimpressive variations, 
consistent with the fact that no significant ADC reduction was observed upper cortical region marked 
by a red arrow in Figure 3.10(C). The reduction of MCA diameter in the ipsilateral side at reperfusion 
day 1 was normalized at reperfusion day 7. In the subcortical area, double box plots show increased 
VSI values (Figure 3.10(G)) and reduced Q values (Figure 3.10(H)) in ipsilateral ischemic edema lesion 
compared to those in the contralateral region at reperfusion day 1. However, the VSI (Figure 3.10(O)) 
and Q (Figure 3.10(P)) values in ipsilateral lesion became similar to those of the contralateral region at 
reperfusion day 7. Corresponding ADC values in the subcortical ischemic edema region were restored. 
The third case shows that abnormal macrovascular remodeling of the pial venous vessels is 
associated with tissue necrosis progression from cortical ischemic edema. In UTE-MRAs, increased 
cRHV and DCV diameters are visible in lateral view of the ipsilateral hemisphere at reperfusion day 4 
(Figure 3.11(A), red arrows). However, no significant diameter change of those vessels is observable 
between reperfusion days 4 and 7 (Figures 3.11(A) and (I), red arrows). Markedly elevated ADC values 
of the cortical area at reperfusion day 7 (Figure 3.11(K), white arrow) indicate the possible occurrence 
of necrosis. At reperfusion day 13, greater increase and expansion of those elevated ADC values were 
observed (Figure 3.12), which further verifies the tissue necrosis.  
However, in the subcortical region, decreased VSI values and increased Q values as reperfusion 
continued from day 4 to day 7 were observed, indicating a normal microvascular recovery in the 
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corresponding region with normal ADC values (Figures 3.11(D), (E), (K), (L), and (M)). Bar graphs 
show the diameters of cRHV, DCV and MCA for ipsilateral (Figure 3.11(F)) and contralateral (Figure 
3.11(N)) hemisphere at day 4 and day 7 after reperfusion with mean ADC values of cortical regions. A 
significant dilation of the pial venous vessels in the ipsilateral area is evident from reperfusion day 4 to 
reperfusion day 7. Thereafter, necrosis proceeded in the cortex. In the subcortical area, double box plots 
show increased VSI values (Figure 3.11(G)) and reduced Q values (Figure 3.11(H)) in ipsilateral 
ischemic edema lesion at reperfusion day 4. However, the VSI (Figure 3.11(O)) and Q (Figure 3.11(P)) 
values of ipsilateral lesion became comparable to those values of the contralateral region at reperfusion 
day 7, and the recovery of the corresponding ADC values in subcortex followed. Thus, in the cortical 
area, sustained macrovascular dilation was observed regardless of normal microvascular remodeling in 
the subcortex. The need for dual contrast MR imaging is again emphasized in order to simultaneously 
investigate heterogeneous macro- and microvascular remodeling in ischemic stroke associated with the 
progression of ischemic edema. 
Figure 3.12 ADC maps of tMCAO rat brain acquired at reperfusion day 13 (same tMCAO rat model 
as in Figure 3.11). 
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Figure 3.13 Statistical analysis of macro- and microvascular remodeling. Mean vessel diameters of 
combined maximum cRHVs and DCVs diameters at early days (from day 1 to day 4) of reperfusion (A, 
three tMCAO rat models marked with star, circle, and diamond symbols). Mean vessel diameters of 
combined cRHVs and DCVs at reperfusion day 7 (B, three tMCAO rat models marked with star, circle, 
and diamond symbols). Mean vessel diameter of combined minimum MCAs at early days (from day 1 
to day 4) of reperfusion (C, three tMCAO rat models marked with star, circle, and diamond symbols). 
Mean vessel diameter of combined MCAs at reperfusion day 7 (D, three tMCAO rat models marked 
with star, circle, and diamond symbols). Corresponding mean ADC values of the cortex were shown. 
Combined VSI values versus ADC values (six cases for ischemic edema and eight cases for 
recovered/normal cases were summarized) in ischemic edema and normal regions of subcortex (E). 
Corresponding histograms of VSI values in ischemic edema and normal regions of subcortex (H). The 
proportions of larger VSI values (> 10 μm) in ischemic edema and normal regions of subcortex are 
respectively shown in the inset figure of H. Combined Q and MVD values versus ADC values in 
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ischemic edema and normal regions of subcortex (F and G), respectively. Corresponding histograms of 
Q and MVD values in ischemic edema and normal regions of subcortex (I and J). The proportions of 
larger MVD values (> 200 mm-2) in ischemic edema and normal regions of subcortex are respectively 
shown in the inset figure of J. *** (p<0.001) and ** (p<0.01) from Student’s t-test. The dotted vertical 
lines mark the ADC = 650 μm2/s, which are set to separate ischemic edema from recovered/normal 
tissue. 
 
3.3.4 Macro- and microvascular remodeling analysis 
14In the cortex, the maximum vessel diameters of cRHV and DCV and the minimum vessel diameter 
of MCA in the ipsilateral brain were respectively combined at early reperfusion days (day 1 and day 4), 
except for the case of cortical necrosis progression. Consistently, the vessel diameters of normalizing 
cRHV, DCV, and MCA in the ipsilateral brain were respectively combined at late reperfusion day (day 
7). Corresponding vessel diameters of the contralateral region were also combined, accordingly. Then, 
the association between mean ADC values of cortical regions and morphological alteration of pial 
venous and arterial vessels from UTE-MRAs were observed. Mean diameters of venous cRHVs and 
DCVs were significantly (p = 0.0051, paired Student’s t-test with combined cRHV and DCV diameters) 
dilated in the lesions of ischemic edema at early reperfusion days and then normalized at late reperfusion 
day with the restoration of corresponding ADC values as shown in Figures 3.13(A) and (B), respectively. 
On the contrary, the mean diameter of arterial MCAs was significantly (p = 0.0096, paired Student’s t-
test) thinned at early reperfusion days and then recovered at late reperfusion day as shown in Figures 
3.13(C) and (D), respectively.  
In the subcortex, the VSI/Q/MVD values in ischemic edema lesions (ADCmean < 650 μm2/s) and 
those values in normal tissue of contralateral hemisphere (ADCmean > 650 μm2/s, recovered ipsilateral 
area included) were also respectively combined for all cases. Then, the association between ADC values 
and VSI/Q/MVD values from  ∆R2-∆R2*-MRI was also revealed. The VSI values showed a non-
Gaussian distribution with a long tail toward larger values as shown in Figure 3.13(E). Compared with 
normal tissues, VSI values in ischemic edema lesions showed wider distribution with significantly (p < 
0.001, unpaired Student’s t-test) increasing relative proportion of larger vessels (VSI > 10 μm). The 
proportion of small vessels (VSI < 10 μm) was observed to be relatively reduced. The Q values of 
ischemic edema lesions were significantly (p < 0.001, unpaired Student’s t-test) smaller than those of 
values in the normal areas as shown in Figure 3.13(F). MVD values in ischemic edema lesions showed 
narrower distribution with significantly (p < 0.001, unpaired Student’s t-test) reduced relative 




3.4 Discussion and conclusions 
To quantitatively evaluate macro- and microvascular remodeling after ischemic stroke, we performed 
dual contrast MRI on tMCAO rat models. To estimate of association of vascular remodeling with 
ischemic edema status, ADC maps were also acquired, which quantitatively represent ischemic tissue 
status [63-65]. T1-contrast-based UTE-MRAs visualized morphological alterations of the 
macrovasculature occurring at the tMCAO rat brain surface region at an isotropic resolution of 59 μm3. 
In response to MCA occlusion, dilated pial venous vessels (cRHV and DCV) were clearly observed at 
early reperfusion days (1 to 4 days) as collateral circulatory role likely to accommodate thinned MCA, 
reflecting the early phase of venous macrovascular dilation. After this dilation, reduced venous vessel 
diameters were visible (7 days after reperfusion), which correlated with the restoration of ADC values. 
In contrast, thinned pial arterial vessel (MCA) was observed at early reperfusion days and restored at 
late reperfusion day (7 days). Because MCA was occluded initially, it is likely that the size of MCA 
was observed to be reduced even at early days of reperfusion and gradually recovered along with ADC 
recovery. Our observations on the different morphological response of pial arterial and venous vessels 
during the ischemic edema recovery would still require further investigations for physiological origins.  
At the same time, the utilization of VSI/Q/MVD maps, which were derived from ∆R2-∆R2*-MRI, 
verified morphological alterations of the microvasculature occurring at the tMCAO rat brain inner 
region. As a comparison of our VSI/Q/MVD values with other previous validation studies, cortical 
regions of contralateral hemispheres for all tMCAO rat models were segmented and combined. Such 
median values of VSI/Q/MVD from all tMCAO rat models were 4.06 μm, 1.07 s-1/3, and 337.4 mm-2, 
respectively. Those values are quantitatively consistent with other validation reports [13,46,66]. 
Consistent with macrovascular remodeling, comparison VSI/Q/MVD values with subcortical ischemic 
edema status revealed an increased proportion of larger VSI values in the subcortical ischemic edema 
lesions. Also, reduced Q and proportion of larger MVD values were observed in the subcortical 
ischemic edema lesions, which are qualitatively consistent with other reports [44,47,67]. Microvascular 
normalization was observed at late reperfusion day (day7) as well. On the other hand, simultaneous 
morphological characterization of macro- and microvasculature showed a significant spatial variation 
of vascular changes. In some cases, even when cortical macrovascular remodeling was normal, 
subcortical microvascular remodeling was observed to correlate with unrestored ischemic edema and 
vice versa. The importance of such whole-brain monitoring of the cerebral vasculature and their 
association with ischemic recovery in multiple length-scales is illustrated in ischemic stroke brains.  
It is also important to note that morphological changes of venous vessels in the post-ischemic stroke 
brain were rarely reported before. Considering the fact venous macrovascular dilations were observed 
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from UTE-MRAs in early reperfusion days, and that the venous cerebral volume fraction reaches 70% 
in the rodent brain [68], observed changes of VSI/Q/MVD values may be partially attributed to changes 
in venous microvasculature in subcortex area as well. Because the ischemic edema (via the ADC) is 
observed to be significantly associated with changes in MR-derived morphological (size and density) 
macro- and microvasculature, multi-length vascular information, including venous vasculature may 
help optimize the drug or treatment strategy after ischemic stroke. However, further quantification of 
sole venous microvascular information in the ischemic brain ideally requires a technical ability to 
differentiate morphologically changes in the arterial and venous systems of the microvascular system.  
The difference in the distribution of VSI values between the subcortical ischemic edema lesion and 
the normal region is informative. In our Monte Carlo simulation, each VSI, Q, and MVD value was 
calculated from a single microvessel radius condition. However, in real cerebrovascular systems, 
various vascular radiuses may co-exist, which may complicate direct interpretation of MR-derived 
microvascular parameters. For example, in Monte Carlo simulation, reduction of relatively small 
vessels or actual dilation of all vessels may provide similarly increased VSI values. Also, if distributions 
of relatively small and large vessels are reduced in similar proportions, VSI values may not change. In 
this case, Q and MVD values should provide complementary information. Experimentally, a significant 
decrease in the Q and MVD values in ischemic edema lesions observed with changes in the VSI 
distribution supports the hypothesis that a number of small vessels decreases and a number of large 
vessels increases in the ischemic edema lesions. To establish the effectiveness of MRI-derived 
microvascular remodeling data for analyzing ischemic stroke progression, a validation study with 
microvessel size distributions may be required, using proven techniques from the previous studies 
[46,48,69]. 
This study also suggests areas for possible technical improvements. First, as the current method 
enables sequential acquisition of perfusion parameters from DSC-MRI as well, combining diffusion 
and vascular morphological and functional information may provide a more complete picture of 
ischemic stroke progression, requiring further optimization of acquisition protocols. Second, high-
resolution dual contrast MRI requires relatively long scan times, which hampers its routine application 
yet. For reduction of scan time, adjusting resolution with MR parameters that can affect scan time is 
necessary. There are several techniques, such as compressed sensing [70], parallel imaging [71], and 
super-resolution reconstruction via deep learning [72,73], that can additionally reduce scan time. 
Further study is required to verify the effectiveness of those techniques for clinical application of dual 
contrast MRI.  
In summary, dual contrast MRI with SPION as a single contrast agent can be successfully performed 
on rat models of tMCAO to simultaneously visualize whole brain macro- and microvascular remodeling 
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after ischemic stroke, including pial venous vessels. Visualization and quantification of such 
simultaneous macro- and microvascular remodeling indicated that MR-based morphological (size and 
density) vessel normalization is directly associated with restored ADC values in post-ischemic stroke 
rat brains. Multiscale monitoring of the cerebrovascular system with dual contrast MRI may further 
elucidate the vascular mechanism of ischemic stroke recovery. 
The original source of Chapter 3 is the article, Kang, M.; Jin, S.; Lee, D.; Cho, H., MRI Visualization 
of Whole Brain Macro-and Microvascular Remodeling in a Rat Model of ischemic Stroke: A pilot Study. 






















Chapter 4. Dual contrast MRI: Application 
4.1 Introduction 
Following an ischemic stroke, multiple neurologic complications, including cerebral edema, 
inflammation, and vascular alteration, develop dynamically during the subacute stage (1 to 7 days). As 
the status of the subacute stage affects the progression of the chronic stage, a detailed investigation of 
the subacute stage of ischemic stroke is crucial. For example, pseudo-normalization of the magnetic 
resonance (MR) apparent diffusion coefficient (ADC) values is typically observed around one week 
after ischemic stroke [74-78]. This is most likely due to a combination of cytotoxic edema (lowering 
ADC, swelling of cells) and the development of vasogenic edema (increasing ADC, swelling of the 
extracellular space) [79-83]. On the other hand, the temporal occurrence of such pseudo-
normalization of the ADC may be spatially heterogeneous in ischemic brains [84,85]. If vasogenic 
edema occurs faster in certain ischemic areas, an accelerated pseudo-normalization of the ADC 
develops, and these lesions more quickly and widely expand into the chronic stage. As a result, detailed 
spatial characterization and diagnosis of early and typical ADC pseudo-normalization lesions and 
subsequent treatment decisions may be important [80,86-88]. However, since these early pseudo-
normalization lesions have a higher ADC (closer to ADC of normal tissue) than typical pseudo-
normalization lesions in the early subacute stage (1 to 4 days), distinguishing these lesions by ADC 
alone can be problematic, especially in the subacute stage. 
Ischemic stroke is induced by cerebrovascular dysfunction and results in vascular remodeling. The 
visualization and quantification of the macro- and microvascular status may help characterize and 
differentiate early and typical pseudo-normalization lesions. Previous MR imaging (MRI) 
investigations of vascular remodeling have revealed a correlation between adequate vascular 
remodeling, recovery, and clinical outcomes after ischemic strokes [27,30,32,35]. However, differential 
MRI characterizations of both vascular morphology and function between early and typical pseudo-
normalization lesions are rare in the subacute stage. Consequently, simultaneous longitudinal 
visualization and quantification of morphological (size/density) and functional (perfusion) vascular 
status in both lesions can provide further insights and prognostic information in addition to general 
measurements of lesion tissue status via the ADC or T2. For example, the segmentation of ischemic 
lesions may elucidate the origins of hyperperfusion and delayed transit time observed in the subacute 
stage by cross-monitoring vascular morphology and function. 
As an investigation of vascular alterations after ischemic stroke, MR angiography (MRA) has shown 
morphological macrovascular remodeling at the brain surface region after ischemic stroke [36,37,39]. 
Microvascular remodeling in the inner brain region can be visualized by morphological mapping of the 
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vessel size index (VSI) and microvessel density (MVD and Q), overcoming the spatial resolution 
limitation of MRA [44-48,89]. Dynamic susceptibility contrast MRI (DSC-MRI) can be used to 
estimate functional microvascular status, such as the cerebral blood volume (CBV), cerebral blood flow 
(CBF), and mean transit time (MTT) in lesions [90-92]. 
In this study, longitudinal morphological and functional vascular remodeling were investigated 
differentially between early and typical pseudo-normalization lesions to assess contrasting vascular 
conditions in a transient middle cerebral artery occlusion (tMCAO) rat model using dual contrast 
superparamagnetic iron oxide nanoparticles (SPION) [89]. Early and typical pseudo-normalization 
lesions were selected and segmented using longitudinally acquired ADC maps. Corresponding VSI and 
MVD maps were generated to evaluate the morphological vascular status. For evaluation of functional 
vascular status, relative CBV (rCBV), CBF (rCBF), and MTT (rMTT) maps from DSC-MRI 
acquisitions were simultaneously analyzed. Ultra-short echo time MRAs (UTE-MRAs) were acquired 
to compare morphological macrovascular remodeling occurring at the brain surface region. For the 
direct validation of VSI, MVD, and rCBV values between two lesions, light sheet fluorescence 
microscopy (LSFM) images of tMCAO rat models were acquired and quantitatively compared at 
reperfusion day 7. 
 
4.2 Materials and methods 
4.2.1 Animal preparation 
Animal experiments were performed in accordance with the Animal Protection Act of Korea under a 
protocol approved by the Institutional Animal Care and Use Committee of the Ulsan National Institute 
of Science and Technology. All experiments were reported in compliance with the ARRIVE guidelines 
(Animal Research: Reporting In Vivo Experiments) [93]. Male Wistar rats (bodyweight 280-320 g, n = 
13) were subjected to focal brain ischemia by transient occlusion of the middle cerebral artery (MCA). 
Initially, rats were anesthetized by inhalation of 3% isoflurane in a mixture of 70% nitrous oxide and 
30% oxygen. Anesthesia was maintained by changing the range of isoflurane to 1-1.5%. Body 
temperature was kept constant (37 ± 1 ℃) through a feedback-controlled heating pad. As previously 
described [52], an intraluminal monofilament (0.37 mm diameter, Doccol Corporation, Redlands, CA, 
USA) was inserted into the external carotid artery and positioned to the internal carotid artery to block 
the MCA. The monofilament was withdrawn after 1 h of occlusion, and rats were housed in a 12 h light-
12 h dark cycle with access to food and water ad libitum. 
 
4.2.2 MRI acquisition 
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MRI acquisitions were conducted using a 7-T MR scanner (Bruker, Ettlingen, Germany). The tMCAO 
rat models were anesthetized using the same method of focal brain ischemia surgery. A single contrast 
agent, SPION, was synthesized in-house according to previously described methods [94]. The core size 
distribution of the iron oxide measured by transmission electron microscopy was 5-10 nm, and the mean 
hydrodynamic diameter of the iron oxide nanoparticles measured by differential light scattering was 
20 ± 7 nm. The r1 and r2 of SPION were 2.36 mM-1s-1 and 32.94 mM-1s-1 at 7-T, respectively. SPION 
was administered as an intravenous bolus with a dose of 75 μmol Fe/Kg for DSC-MRI acquisition, and 
an additional SPION dose of 285 μmol Fe/Kg (total 360 μmol Fe/Kg) was administered for ∆R2, ∆R2*, 
and UTE-MRA acquisitions. Longitudinal MRI acquisitions of tMCAO rat models were performed at 
reperfusion days 1, 4, and 7. Morphological and functional microvascular remodeling (VSI and MVD 
and DSC-MRI, respectively) were acquired for all (n = 11) tMCAO rat models, and macrovascular 
remodeling (UTE-MRA) was acquired for two representative tMCAO rat models showing early 
pseudo-normalization and typical pseudo-normalization in the cortex lesions. 
The ADC map was acquired using a diffusion-weighted echo planar imaging (EPI) pulse sequence 
with the following parameters: TR/TE = 3500/26.6 ms, number of averages (NA) = 8, number of 
segments = 3, b-values = 100, 200, 400, 600, 800, and 1000 s/mm2, flip angle (FA) = 90 °, matrix size 
= 100 × 100, field of view (FOV) = 30 × 30 mm2, resolution = 300 × 300 μm2, number of slices = 8, 
and slice thickness = 1 mm. Three directional (x, y, and z) ADC maps were acquired and averaged. 
The DSC-MRI perfusion maps were acquired using a gradient-echo EPI pulse sequence with the 
following parameters: TR/TE = 420/17 ms, NA = 1, number of segments = 1, number of repetitions = 
400, FA = 30 °, matrix size = 96 × 96, FOV = 30 × 30 mm2, resolution = 313 × 313 μm2, number of 
slices = 8, and slice thickness = 1 mm. 
The ∆R2 map was acquired using a multi-slice multi-echo pulse sequence with the following 
parameters: TR = 6000 ms, TE = 8-160 ms, echo spacing = 8 ms, NA =1, FA = 90 °, matrix size = 
256 × 256, FOV = 30 × 30 mm2, resolution = 117 × 117 μm2, number of slices = 8, and slice thickness 
= 1 mm. 
The ∆R2* map was acquired using a multi-echo gradient-echo pulse sequence with the following 
parameters: TR = 6000 ms, TE = 3-59 ms, echo spacing = 4 ms, NA = 1, FA = 90 °, matrix size = 
256 × 256, FOV = 30 × 30 mm2, resolution = 117 × 117 μm2, number of slices = 8, and slice thickness 
= 1 mm. 
The UTE-MRA was acquired using the UTE pulse sequence with the following parameters: TR/TE 
= 22/0.012 ms, NA = 1, FA = 40 °, under-sampling factor = 1.13, matrix size = 512 × 512 × 512, FOV 




4.2.3 Fluorescence image acquisition 
To label cerebral blood vessels, fluorescein isothiocyanate (FITC)-dextran solution was heart perfused 
in two representative tMCAO rat models, which showed early pseudo-normalization and typical 
pseudo-normalization in the cortex lesions at reperfusion day 7 according to the previously described 
methods [95]. One hundred milliliters of saline solution was administered into the left ventricle to 
extract cerebrovascular blood through the right atrium. Subsequently, FITC-dextran was mixed with 5% 
gelatin solution at a concentration of 0.075% and administered into the left ventricle. After 30 min of 
refrigeration, the rat brain was dissected and fixed in 4% paraformaldehyde (PFA) for two days. Then, 
2 mm of the brain, including the edema lesion, was dissected. Tissue clearing was then performed to 
acquire 3-dimensional structural images using a Binaree tissue clearing™ kit (Cat. HRTC-001; Binaree, 
Korea). In brief, the tissue was immersed in the Binaree tissue clearing solution, which was changed 
every two to three days until the sample was visibly clear. The brains were transferred to Binaree 
Mounting and Storage™ Solution (Cat. SHMS-060, Binaree) for refractive index matching. 
Subsequently, using LSFM (Zeiss Lightsheet Z.1), 3-dimensional fluorescence images of tissue-cleared 
tMCAO rat brains were acquired with a resolution of 1.2 × 1.2 × 5.2 μm3. In addition, 4% PFA fixed 
brains were embedded in OCT compound and dissected using a cryostat (Leica) at a thickness of 
100 μm. Fluorescence images were acquired at a resolution of 0.8 × 0.8 μm2 using a fluorescence stereo 
zoom microscope (Zeiss Axio Zoom. V16) with a 38 Zeiss filter (excitation wavelength of 470 ± 40 
nm and an emission wavelength of 525 ± 50 nm). 
 
4.2.4 Data processing and analysis 
MATLAB (MathWorks, Natick, MA) and ImageJ (US National Institutes of Health, Bethesda, MD) 
software were used for the data processing and analysis. Voxel-wise ADC values were estimated by 
fitting the equation S = S0× 𝑒−ADC×b with a nonlinear least-squares fitting method using MATLAB. b 
refers to the b-value for the corresponding MRI acquisition. Acquired ADC maps were up-sampled to 
a size of 256 × 256 for VSI and MVD calculations. 
rCBV, rMTT, and rCBF maps were acquired using DSC-MRI. Initially, time-series signal intensity 







where Spre is an averaged signal before the administration of SPION. Subsequently, the area under the 
curve of ∆R2*(t) was measured after fitting ∆R2*(t) with the gamma-variate function to calculate the 
indices of rCBV, MTT, and rCBF using rCBVindex = ∫ ∆
𝑡
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 [96]. Finally, each rCBV, rMTT, and rCBF map was generated by dividing the index by the 
median value of the contralateral corpus callosum region indices for each tMCAO rat model. 
The ∆R2 and ∆R2* values were calculated by subtracting the transverse relaxation rate (R2 and R2*) 
values acquired before the administration of SPION from the respective values acquired after the 
administration of SPION. The voxel-wise R2 and R2* values were estimated by fitting the equation S = 
S0× 𝑒−TE×[R2 or R2
∗]. ∆R2 and ∆R2* maps were used to determine the VSI and MVD maps using the 
following equations [13,14]: 
VSI (μm) = 0.424(ADC/(γ∆χB0))1/2(∆R2*/∆R2)3/2 (1) 
MVD (mm-2) ≈ Q3/(4.725ADC) (2) 
where γ is the proton gyromagnetic ratio, ∆χ is the magnetic susceptibility difference between the vessel 
and tissue, and B0 is the magnetic field strength. ∆χ was estimated by ∆χ = 
3∆R2
∗
4π BVf γ B0 
, where BVf is the 
blood volume fraction. In addition, the microvessel density index Q was estimated by Q (s-1/3) 
= ∆R2/(∆R2*)2/3. 
Acquired UTE-MRAs were denoised and visualized using 3D Slicer software (www.slicer.org) to 
investigate macrovascular remodeling in the tMCAO rat models [89]. The caudal rhinal veins (cRHVs), 
populated in the contralateral and ipsilateral regions for each representative tMCAO rat model, were 
selected and segmented for macrovascular remodeling. Vessel diameters of the segmented cRHVs were 
calculated using BoneJ software integrated with ImageJ [60]. In addition, the SD of each cRHV was 
derived. 
Due to the DSC-MRI-derived rCBV maps’ low spatial resolution, rCBV maps were replaced with 
high spatial resolution ∆R2* maps. The values of the ADC, T2, VSI, MVD, CBV (∆R2*), rCBF, and 
rMTT in early pseudo-normalization lesions, typical pseudo-normalization lesions, and contralateral 
regions were calculated and quantitatively evaluated. Subsequently, the relationship of vascular 
remodeling according to the status of cerebral edema was compared. A Mann-Whitney U test was 
performed to compare significant differences between early and typical pseudo-normalization lesions. 
To validate the difference in MRI-derived microvascular remodeling between early and typical pseudo-
normalization lesions at reperfusion day 7, the vessel radius, vessel density, and blood volume fraction 
from the LSFM images were evaluated. The LSFM images were resized to an isotropic resolution of 
1  × 1  × 1  μm3. Three different regions of interest (ROIs) were selected for each early pseudo-
normalization, typical pseudo-normalization lesions, and contralateral regions (total 12 ROIs). Then, 
the vessel radii were measured using BoneJ software with the same process as the vessel diameter 
calculation of UTE-MRA. The vessels in the segmented ROIs were counted using ImageJ software to 




4.3.1 Early pseudo-normalization and typical pseudo-normalization lesions 
Even though the pathogenesis of cerebral edema after ischemic stroke is complex, the underlying ADC 
dependence of early pseudo-normalization and typical pseudo-normalization lesions with associated 
vascular remodeling are conceptualized in Figure 4.1. To address the heterogeneity in the pseudo-
normalization of ADC in ischemic lesions, two different edema progressions, marked by gold and green 
solid lines, are shown in Figure 4.1(A). The gold line shows the pseudo-normalization of ADC before 
reperfusion day 7 as marked by gold arrow (early pseudo-normalization), while the green line shows 
the pseudo-normalization of ADC at reperfusion day 7 as marked by green arrow (typical pseudo-
normalization). The gold line shows a much higher ADC than the green line at reperfusion day 7. In 
Figure 4.1(B), the exemplar MRI-derived morphological VSI map and functional rCBF map are both 
visualized along with volume-rendered LSFM images, which were quantitatively analyzed and 
compared between the lesions of early and typical pseudo-normalization of ADC in the current study. 
 
 
Figure 4.1 Conceptual illustration of edema progression in typical pseudo-normalization and early 
pseudo-normalization lesions. (A) ADC alterations in typical pseudo-normalization (green solid line) 
and early pseudo-normalization (gold solid line) lesions as reperfusion continued from day 1 to 7. The 
black dashed line indicates the ADC value of normal tissue. Two different time points of ADC pseudo-
normalization in early and typical pseudo-normalization lesions are marked by gold and green arrows, 
respectively. (B) Exemplar MRI-derived morphological vascular remodeling related VSI map, 
functional vascular remodeling related rCBF map, and volume-rendered LSFM images to characterize 
vascular remodeling in typical pseudo-normalization and early pseudo-normalization lesions. 
 
4.3.2 Morphological and functional microvascular remodeling mapping 
Overall, Figure 4.2 shows longitudinally (reperfusion days 1, 4, and 7) acquired edema status surrogate 
(T2 and ADC) maps with morphological (VSI and MVD) and functional (CBV, rCBF, and rMTT) 
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microvascular maps of a representative tMCAO rat model. At reperfusion day 1, the area of increased 
T2 with decreased ADC indicates the edema lesion, as marked by yellow arrows in shown in Figures 
4.2(A) and (B), respectively. Correspondingly, morphological (increased VSI and decreased MVD) and 
functional (reduced rCBF and elongated rMTT) microvascular variations are spatially matched with the 
corresponding edema lesion as shown in Figures 4.2(C), (D), (F), and (G), respectively. At reperfusion 
day 4, a slight decrease in T2 and an increase in ADC values with respect to those values at reperfusion 
day 1 were observed, as shown in Figures 4.2(H) and (I), respectively. Along with such edema 
progression, spatially heterogeneous morphological and functional microvascular alterations are 
apparent (Figures 4.2(J), (K), (L), (M), and (N)). Specifically, there are conspicuous lesions marked by 
red arrows in Figures 4.2(H) and (I), which exhibit significantly increased T2 and ADC. Such areas 
represent so-called early pseudo-normalization lesions. Even at reperfusion day 7, early pseudo-
normalization lesions (ADC > 1500  μm2/s at reperfusion day 7) were observed with persistently 
enlarged VSI and reduced MVD values with respect to those values at reperfusion day 4, as shown in 
Figures 4.2(P), (Q), and (R). On the other hand, typical pseudo-normalization (ADC ~ 800 μm2/s at 
reperfusion day 7) tended to restore the morphological and functional microvascular parameters (except 
for rMTT), as shown in Figures 4.2(P), (Q), (R), (S), and (T). 
 
 
Figure 4.2 The representative lesion tissue status, as well as morphological and functional 
microvascular remodeling maps of one tMCAO rat model. (A-U) Longitudinally (at reperfusion days 
1, 4, and 7) acquired lesion tissue status related T2 and ADC maps, morphological microvascular 
remodeling related VSI and MVD maps, and functional microvascular remodeling related CBV, rCBF, 
and rMTT maps of one tMCAO rat model. The yellow arrows indicate edema lesion and red arrows 
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indicate early pseudo-normalization lesions. 
 
4.3.3 ROI selection for early and typical pseudo-normalization lesions and the contralateral 
region 
According to the ADC maps, typical pseudo-normalization, early pseudo-normalization lesions, and the 
contralateral region were selected and segmented, as shown in Figure 4.3. To cover whole-brain cerebral 
edema, three or four slices of each ADC map were used. At reperfusion day 1, ADC values under 
650 μm2/s were considered as edema lesions and segmented as typical pseudo-normalization lesions, as 
indicated by the yellow boundary line in Figure 4.3(A). Then, the mirror region in the contralateral 
hemisphere was segmented as the contralateral region, as indicated by the green boundary line in Figure 
4.3(A). Based on the segmented typical pseudo-normalization lesion and contralateral region at 
reperfusion day 1, the same ROIs were registered to the ADC maps of reperfusion days 4 and 7 and 
segmented (Figures 4.3(B) and (C)). In addition, vasogenic edema dominant and early pseudo-
normalization lesions were selected and segmented. At reperfusion day 7, ADC values over 1500 μm2/s 
were considered as vasogenic edema dominant and segmented as early pseudo-normalization lesions, 
as indicated by the red boundary line in Figure 4.3(C). The ventricle regions show ADC values over 
1500 μm2/s and if they are included in early pseudo-normalization lesions, they can induce bias to 
various vascular remodeling parameters. However, as accelerated vasogenic edema induced early 
pseudo-normalization lesions are structurally distinct from ventricle regions, the ventricle regions were 
not included in early pseudo-normalization lesions. Based on the segmented early pseudo-normalization 
lesion at reperfusion day 7, the same ROI was registered to the ADC maps of reperfusion days 1 and 4. 
From the mask of typical pseudo-normalization ROIs, the lesions of early pseudo-normalization ROIs 
were excluded for all reperfusion days. In addition, at each reperfusion day, the mirror region of the 
early pseudo-normalization lesion in the contralateral region was included as the contralateral region. 





Figure 4.3 Respective ROIs for a typical pseudo-normalization lesion, early pseudo-normalization 
lesion, and contralateral region. (a-c) Selected ROIs for the typical pseudo-normalization lesion (yellow 
boundary lines, ADC < 650  μ m2/s at reperfusion day 1), early pseudo-normalization lesion (red 
boundary lines, ADC > 1500 μm2/s at reperfusion day 7), and contralateral region (green boundary lines) 
at reperfusion day 1, 4, and 7. The contralateral region was selected as mirror regions of both typical 
and early pseudo-normalization lesions. 
 
4.3.4 Comparisons of the morphological and functional microvascular remodeling 
Next, a total of 33 cases of each of the ADC, T2, and morphological and functional microvascular 
parameters were longitudinally (reperfusion day 1, 4, and 7) mapped for the 11 tMCAO rat models. 
Their median values were compared among the three ROIs, that is, typical and early pseudo-
normalization lesions and the contralateral region. Figure 4.4 shows violin plots (distributions, median 
values, and interquartile ranges) of the edema status (ADC and T2), as well as the morphological (VSI 
and MVD) and functional (CBV, rCBF, and rMTT) microvascular alterations of typical (blue) and early 
(red) pseudo-normalization lesions according to reperfusion days 1, 4, and 7. The median values are 
connected with dashed lines to evaluate the trend of vascular remodeling. In addition, the median values 
of the contralateral regions are connected with solid lines (orange) as reference values. In ADC, early 
pseudo-normalization lesions exhibited a median ADC value comparable to that of the contralateral 
region around reperfusion day 2, while typical pseudo-normalization lesions displayed it around 
reperfusion day 7 (Figure 4.4(A)). Elevated median T2 values in typical and early pseudo-normalization 
lesions decreased over time (Figure 4.4(B)), except that early pseudo-normalization lesions showed 
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increasing median T2 values as reperfusion continued from day 4 to 7. For morphological microvascular 
alterations, early pseudo-normalization lesions showed higher median VSI values than typical pseudo-
normalization lesions at reperfusion days 4 and 7, while similar values were observed at reperfusion 
day 1 (Figure 4.4(C)). In addition, early pseudo-normalization lesion showed increased macrovascular 
diameter in UTE-MRAs compared to typical pseudo-normalization lesion as shown in Figure 4.5. In 
Figure 4.5(Q) and (R), the estimated cRHV diameters are shown as bar graphs. Both of the tMCAO rat 
models showed no significant alteration of cRHVs in the contralateral regions (orange) as reperfusion 
continued until day 7. In typical pseudo-normalization lesions, enlarged cRHV at reperfusion day 4 
decreased at reperfusion day 7, indicating normalization of the macrovasculature (blue). However, in 
early pseudo-normalization lesions, enlarged cRHV at reperfusion day 4 did not significantly decrease 
at reperfusion day 7 compared to typical pseudo-normalization lesions (red). Early pseudo-
normalization lesions showed lower median MVD values than typical pseudo-normalization lesions at 
all reperfusion days (Figure 4.4(D)). However, typical pseudo-normalization lesions showed increased 
median MVD values as reperfusion continued from day 4 to 7, while early pseudo-normalization lesions 
showed persistently lowered median MVD values. For functional microvascular alterations, early 
pseudo-normalization lesions showed higher median CBV and rCBF values than typical pseudo-
normalization lesions at reperfusion days 4 and 7 (Figures 4.4(E) and (F), respectively). Early pseudo-
normalization lesions showed higher median rMTT values than typical pseudo-normalization lesions at 
all reperfusion days (Figure 4.4(G)). As reperfusion continued from day 4 to 7, the median values of 
rMTT in early pseudo-normalization lesions became further elongated. For detailed distribution 
comparisons between typical pseudo-normalization lesions and contralateral regions, violin plots are 
shown in Figure 4.6. After Anderson-Darling tests for normal distribution decision, all Mann-Whitney 
U tests showed significant differences between typical pseudo-normalization and early pseudo-






Figure 4.4 Violin plots of the lesion tissue status as well as morphological and functional microvascular 
remodeling. (A-G) Violin plots (distributions, median values, and interquartile ranges) of the lesion 
tissue status related ADC and T2, morphological microvascular remodeling related VSI and MVD, and 
functional microvascular remodeling related CBV, rCBF, and rMTT in typical pseudo-normalization 
(blue) and early pseudo-normalization (red) lesions at reperfusion days 1, 4 and 7. The solid orange 
lines indicate the connected median values of the contralateral regions. The median values of each 
typical pseudo-normalization and early pseudo-normalization lesion were connected with dashed lines 
as reperfusion continued from days 1 to 7. The X marks indicate that no significant difference between 
typical and early pseudo-normalization lesions was found in the statistical analysis (T2 and VSI at 











Figure 4.5 Comparison of macrovascular remodeling between typical pseudo-normalization and early 
pseudo-normalization lesions. (A-D) Lateral views of ipsilateral hemispheres in UTE-MRAs of two 
representative tMCAO rat models showing typical pseudo-normalization and early pseudo-
normalization in cortical lesions at reperfusion days 4 and 7. The red arrows indicate the caudal rhinal 
veins (cRHVs) in the ipsilateral hemispheres. (E-L) Thickness maps of segmented cRHVs in the 
ipsilateral and contralateral hemispheres according to acquired UTE-MRAs. The blue letters represent 
cRHVs in the ipsilateral hemispheres of the tMCAO rat model showing typical pseudo-normalization 
at reperfusion days 4 and 7 (E and G, respectively). The red letters represent cRHVs in the ipsilateral 
hemispheres of the tMCAO rat model showing early pseudo-normalization at reperfusion days 4 and 7 
(I and K, respectively). The orange letters represent cRHVs in the contralateral hemispheres of two 
tMCAO rat models (F, H, J, and L). (M-P) The ADC maps of typical pseudo-normalization and early 
pseudo-normalization lesions showing two tMCAO rat models at reperfusion days 4 and 7. The white 
arrow indicates vasogenic edema dominant and early pseudo-normalization lesions in the cortex. (Q 
and R) Bar graphs of the cRHV vessel diameters in the ipsilateral and contralateral hemispheres for 
typical pseudo-normalization and early pseudo-normalization lesions showing two tMCAO rat models 
at reperfusion days 4 and 7. The dashed lines show the vessel diameter alterations from reperfusion day 








Figure 4.6 Violin plots for histograms and interquartile ranges comparison between typical pseudo-
normalization lesion and contralateral region. (a-g) Violin plots of tissue status related ADC and T2, 
morphological microvasculature related VSI and MVD, and functional microvasculature related CBV, 
rCBF, and rMTT in typical pseudo-normalization lesion (blue) and contralateral region (orange) at 
reperfusion days 1, 4, and 7. Median values are connected with dashed lines.  
 
4.3.5 Correlations between the VSI versus rCBF and the MVD versus rMTT 
Scatter plots of the VSI versus rCBF for hyperperfused and the MVD versus rMTT for transit-delay 
regions are shown in Figure 4.7 to investigate the relationships between morphological and functional 
microvascular parameters. The results especially link hyperperfusion versus vessel size and delayed 
transit time versus vessel density. Individual median VSI, rCBF, MVD, and rMTT values were acquired 
from three ROIs (typical pseudo-normalization, early pseudo-normalization lesions, and the 
contralateral region) of each tMCAO rat model for each reperfusion day and are shown in a scatterplot 
in Figure 4.7(A) and (B) (cases with hyperperfusion (A) and delayed transit time (B) were considered). 
Subsequently, the group median VSI, rCBF, MVD, and rMTT values of all tMCAO rat models were 
scatter-plotted, as shown in Figure 4.7(C) and (D). The group median values of typical pseudo-
normalization (triangle) and early pseudo-normalization (star) lesions were separately included in 
scatterplots. After Anderson-Darling tests for normal distribution decision, an individual comparison of 
the VSI and rCBF showed a positive correlation (r = 0.454, p < 0.001 from paired student’s t-test) 
(Figure 4.7(A)), while the group comparison showed a strong positive correlation (r = 0.92, p < 0.001 
from paired student’s t-test) (Figure 4.7(C)). Increased vessel size appears to be related to observed 
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hyperperfusion in subacute ischemic lesions. On the contrary, an individual comparison of the MVD 
and rMTT showed a negative correlation (r = -0.415, p < 0.001 from Wilcoxon signed-rank test) (Figure 
4.7(C)), and the group comparison also showed a negative correlation (r = -0.477, p = 0.012 from paired 
student’s t-test) (Figure 4.7(D)). Individual comparison of the MVD and rMTT (blue circles) showed a 
much higher correlation at reperfusion day 7 than that at reperfusion days 1 (red circles) and 4 (green 
circles) with r = -0.604 and p < 0.001 from Wilcoxon signed-rank test (inset figure of Figure 4.7(B)). 
This was presumably due to the distinct differences in the MVD and rMTT between early and typical 
pseudo-normalization lesions at reperfusion day 7. In addition, from the group median comparisons, 
increasing rMTT values were pair-wisely observed for early pseudo-normalization lesions with 




Figure 4.7 Correlations between the VSI versus rCBF and the MVD versus rMTT. (A and B) Scatter 
plots of the median rCBF and rMTT values over the averaged median rCBF and rMTT values in the 
contralateral regions of each tMCAO rat model with the corresponding median VSI and MVD values 
according to reperfusion day 1 (red circles), 4 (green circles), and 7 (blue circles). (inset figure of (B)) 
Scatter plot of MVD and rMTT at reperfusion day 7. Correlation coefficient r = 0.454, r = -0.415, and 
r = -0.604 and p-values < 0.001 from the paired student’s t-test and Wilcoxon signed-rank tests, 
respectively. (C and D) Scatter plots of the median VSI versus rCBF and the MVD versus rMTT values 
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of typical pseudo-normalization (triangle) and early pseudo-normalization lesions (star) from all 
tMCAO rat models according to reperfusion day 1 (red), 4 (green), and 7 (blue). Correlation coefficient 
r = 0.92 and r = -0.477 and p < 0.001 and p = 0.012 from the paired student’s t-tests, respectively. The 
black solid lines indicate the fitted lines. The orange dashed lines indicate the average median rCBF 
and rMTT values of the contralateral regions. 
 
4.3.6 Comparisons of the MRI- and LSFM-derived microvascular parameters 
To validate the microvascular parameters of the VSI, MVD, and CBV (∆R2*) derived from MRI, LSFM 
images of two representative tMCAO rat models exhibiting typical pseudo-normalization and early 
pseudo-normalization in cortex lesions were acquired and quantitatively compared. The contralateral 
regions and ipsilateral lesions were separately compared in Figures 4.8 and 4.9, respectively. For each 
tMCAO rat model, six ROIs were selected and analyzed. Figure 4.10(A) shows six representative ROIs 
(three red ROIs in the ipsilateral lesion and three blue ROIs in the contralateral region) in the maximum 
intensity projection (MIP) image of 64 μm thickness LSFM images. In addition, a volume-rendered 
LSFM image via Imaris software (Bitplane, Switzerland) at a thickness of 2 mm is shown for reference 
in Figure 4.10(B) and addresses the 3-dimensional nature of LSFM images. 
MRI-derived morphological microvascular parameters of the VSI and MVD values in the 
contralateral cortex regions were acquired through six slices at reperfusion day 7 for each tMCAO rat 
model, and an exemplar ROI is shown as a yellow region overlapped on the VSI and MVD maps, as 
shown in Figure 4.8(A) and (B), respectively. The median values of the VSI and MVD of each tMCAO 
rat model are shown as green dashed lines in Figures 4.8(C) and (D), respectively, for 11 cases. The red 
lines show the averaged VSI and MVD values of 11 tMCAO rat models, which are 4.2 μm and 314.2 
mm-2, respectively. MIP images of 64 μm thickness LSFM images are shown in Figures 4.8(E) and (F). 
In addition, two ROIs (blue boxes) in the contralateral cortex regions with zoomed-in volume-rendered 
images of each ROI are shown. The mean vessel radius and vessel density were calculated at six ROIs 
in the contralateral cortex regions (three ROIs for each tMCAO rat model) as blue dashed lines in 
Figures 4.8(G) and (H), respectively. The red lines show the average values of the mean vessel radius 
and vessel density, which are 4.26 μm and 286.3 mm-2, respectively. The mean vessel radius and vessel 
density in Figures 4.8(G) and (H) were calculated from the thickness of 256 μm and 4 μm, respectively, 
as marked with red arrows in Figures 4.8(I) and (J), respectively. In the contralateral cortex region, the 
MRI-derived average VSI and MVD values and LSFM-derived average values of the mean vessel 
radius and vessel density were quantitatively comparable. To further investigate the thickness 
dependence of the LSFM-derived parameters, the mean vessel radius, vessel density, and BVf were 
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calculated according to the LSFM image thicknesses of 4, 8, 16, 32, 64, 128, and 256 μm, as shown in 
Figures 4.8(I), (J), and (K), respectively. The mean vessel radius, vessel density, and BVf of the six 
ROIs were averaged at each thickness. As the thickness increased, the vessel radius (~ 4 μm) and BVf 
(~ 2.5%) were not significantly altered, while the vessel density increased, which is also directly visible 
in the volume-rendered images of one ROI in the contralateral region according to various thicknesses 
as shown in Figure 4.11. 
 
 
Figure 4.8 Quantitative comparisons of the MRI- and LSFM-derived vessel size and vessel density in 
the contralateral cortex regions. (A and B) Exemplar VSI and MVD maps at reperfusion day 7. The 
yellow arrows and overlapped yellow regions in each map indicate the segmented ROI in the 
contralateral cortex region for comparison. (C and D) Plots of the MRI-derived median VSI and MVD 
values in the contralateral cortex region for each tMCAO rat model. (E and F) MIP images of 64 μm 
thickness LSFM images of two representative tMCAO rat models and two ROIs (blue boxes) with 
zoomed-in volume-rendered images. (G and H) Plots of the LSFM-derived mean vessel radius and 
vessel density at each ROI. The red solid lines indicate the average values of the vessel sizes and 
densities derived from MRI and LSFM. (I-K) Comparison of the average mean vessel radii, vessel 
densities, and BVfs of six ROIs (three ROIs for each tMCAO rat model) according to the thickness of 
the LSFM image. The red arrows indicate the thickness of the LSFM image for the mean vessel radius 
and vessel density calculation and comparison (G and H, respectively). 
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Next, the ipsilateral cortex lesions of two representative cases were compared, as shown in Figure 
4.9. MIP images of 64 μm thickness LSFM images are shown in Figures 4.9(A) and (B). In addition, 
two ROIs (blue boxes) in the ipsilateral cortex lesions with zoomed-in volume-rendered images of each 
ROI are shown in Figures 4.9(C) and (D). Figure 4.9(C) visually shows a larger vessel size and lower 
vessel density compared to those of Figure 4.9(D). At reperfusion day 1, cerebral edema was observed 
in both T2-weighted images (Figures 4.9(E) and (F)). However, at reperfusion day 7, the ADC map 
showed abnormally increased ADC values compared to those of the contralateral regions in Figure 
4.9(G), which is a signature of vasogenic edema dominant and early pseudo-normalization lesions. The 
other tMCAO rat model showed a typical pseudo-normalization case (Figure 4.9(H)). For LSFM images 
of thicknesses of 4, 8, 16, 32, 64, 128, and 256 μm, the average mean vessel radius, vessel density, and 
BVf of three ROIs for each tMCAO rat model are shown in Figures 4.9(I), (J), and (K), respectively. 
The early pseudo-normalization lesion showed a higher mean vessel radius than the typical pseudo-
normalization lesion for all thicknesses (Figure 4.9(I)). A similar trend was observed for the BVf 
comparison in Figure 4.9(K). The early pseudo-normalization lesion showed a lower vessel density than 
the typical pseudo-normalization lesion for all thicknesses (Figure 4.9(J)). For quantitative comparison 
between the LSFM- and MRI-derived vascular parameters (size, density, and blood volume), the ratios 
between typical and early pseudo-normalization lesions were compared, as shown in Figures 4.9(L), 
(M), and (N), respectively. The ratios of MRI-derived vascular parameters were calculated from the 
median values of all tMCAO rat models at reperfusion day 7. The LSFM-derived ratios were in 
comparable ranges compared to those that were MRI-derived as marked by red arrows. 
Fluorescence images acquired using a fluorescence stereo zoom microscope (without tissue clearing) 
also verified morphological microvascular remodeling differences between early and typical pseudo-
normalization lesions, as shown in Figure 4.12. Figures 4.12(G), (I), (H), and (J) show zoomed-in 
images of ROIs in typical pseudo-normalization lesions (blue box), early pseudo-normalization lesions 
(red box), and contralateral regions (orange boxes), respectively. The zoomed-in images show increased 






Figure 4.9 Quantitative comparisons of the MRI- and LSFM-derived vessel size, vessel density, and 
blood volume in the ipsilateral cortex lesions. (A and B) MIP images of 64 μm thickness LSFM images 
of early pseudo-normalization and typical pseudo-normalization in different tMCAO rat models. (C and 
D) Zoomed-in volume-rendered images of ROIs (red boxes) in (A) and (B). (E and F) T2-weighted 
images at reperfusion day 1. (G and H) ADC maps at reperfusion day 7. (I-K) Comparison of the LSFM-
derived averaged mean vessel radii, vessel densities, and BVfs of three ROIs according to the thickness 
of LSFM image in early pseudo-normalization (green dashed lines) and typical pseudo-normalization 
lesions (yellow dashed lines). (L-N) The ratios of vessel size, vessel density, and blood volume 
according to the LSFM image thickness between typical pseudo-normalization (TP) and early pseudo-
normalization (EP) lesions. The red arrows indicate the ratios of vessel size (VSI), vessel density 





Figure 4.10 Representative LSFM images for visualization of ROIs and whole vasculature. (A) MIP 
image of 64 μm thickness LSFM images with three ROIs in ipsilateral lesion (red boxes) and three ROIs 
in contralateral region (blue boxes). (B) Volume-rendered LSFM image at thickness of 2 mm.    
 
 
Figure 4.11 Volume-rendered LSFM images of one ROI in contralateral region at various thicknesses. 
(A-E) Volume-rendered LSFM images of selected one ROI in contralateral region for 3-dimensional 





Figure 4.12 Fluorescence stereo zoom microscope image (without tissue clearing) of two tMCAO rat 
models showing typical pseudo-normalization and early pseudo-normalization in cortex lesion. (A and 
D) T2 weighted images at reperfusion day 1. (B and E) ADC maps at reperfusion day 7. (C and F) 
Fluorescence images of two tMCAO rat models with ROIs. Blue arrow with blue box indicates ROI of 
typical pseudo-normalization lesion in cortex. Red arrow with red box indicates ROI of early pseudo-
normalization lesion in cortex. Orange arrows with orange boxes indicates ROIs of contralateral region 
in cortex. (G) Zoomed-in images of blue box in typical pseudo-normalization lesion, (H) orange box in 
contralateral region, (I) red box in early pseudo-normalization lesion, (J) and orange box in contralateral 
region.  
Figure 4.13 Longitudinally acquired ADC maps of two tMCAO rat models showing different vasogenic 














Figure 4.14 Results of Monte Carlo simulation. Comparison of simulated MVD with true vessel density 
according to BVfs of 2, 4, 6, and 8%. Zoomed-in image (up to true vessel density of 300 mm-2) is shown 
in inset figure. 
 
4.4 Discussion and conclusions 
After a week of reperfusion, tMCAO rat models showed typical pseudo-normalization lesions in the 
ADC maps. However, there were spatiotemporally different lesions showing early pseudo-
normalization of the ADC before then. Accordingly, typical pseudo-normalization and early pseudo-
normalization lesions were separately investigated using the edema status (ADC and T2), and 
morphological (VSI and MVD), and functional (rCBF and rMTT) vascular remodeling longitudinally. 
It should be noticed that focal brain ischemia was systematically induced without monitoring of 
sequential ADC or CBF, which may result in potential bias to acquired data because of inconsistently 
occluded MCA. At reperfusion day 1, tMCAO rat model showing no edema lesion in T2-weighted 
image and/or ADC map was excluded from this study. Although heterogeneous morphological and 
functional microvascular remodeling were observed, correlative responses between them during the 
progression of ischemic stroke have not been well established. In a clinical study, hyperperfusion was 
observed after recanalization, and there is controversy regarding its effectiveness in hyperperfusion. 
Some cerebral hemodynamic studies have reported that hyperperfusion is a sign of successful 
recanalization with better clinical outcomes [97-100], while others have reported that hyperperfusion is 
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correlated with hemorrhagic transformation [97,101,102]. It should be considered that in this study, 
early pseudo-normalization lesions showed higher rCBF values compared to typical pseudo-
normalization lesions. As early pseudo-normalization lesions have a dominance of vasogenic edema, 
such lesions are more likely to accompany the damaged blood-brain barrier. Thus, hyperperfusion 
observed in the subacute stage requires cautionary interpretation. The relationship between vascular 
size and blood volume (flow) in the subacute stage is also informative. Morphological vascular 
alteration was observed to regulate the CBF [103,104], and this study highlights that hyperperfusion in 
the subacute stage is driven by enlarged vessel size, even with reduced vessel density and delayed transit 
time. Besides hyperperfusion, delayed transit time was also observed in lesions. A previous study 
reported that the net extraction of oxygen negatively correlates with the capillary transit time and is 
limited mainly by capillary density [105]. The observed delayed transit time and low microvessel 
density may implicate delayed metabolism due to delayed oxygen and nutrient supply to the lesion. In 
addition, the association of delayed transit time with respect to low microvessel density provides insight 
into the role of capillaries in regulating (limiting) the CBF. Although confounding correlations may 
exist between morphological and functional microvascular remodeling, this result emphasizes the 
importance of monitoring morphological and functional vascular remodeling after ischemic stroke. 
Further investigation of vascular remodeling and lesion tissue status is required to estimate the recovery 
or progression of ischemic stroke in the acute stage. 
 It is important to emphasize that early pseudo-normalization lesions showed faster and more 
extensive expansion in the chronic stage. For example, in Figure 4.13, two tMCAO rat models showed 
different vasogenic edema dominancy in lesions at reperfusion day 7 (Figures 4.13(E) and (F)). A 
tMCAO rat model showing an extensive vasogenic edema dominant and early pseudo-normalization 
lesion at reperfusion day 7 displayed much faster expansion of early pseudo-normalization lesions at 
the chronic stage (reperfusion days 16 and 25), as shown in Figures 4.13(G), (H), (I), and (J). In 
connection with aggravation of early pseudo-normalization lesion, unnormalized morphological and 
functional vascular remodeling were observed compared to those of typical pseudo-normalization 
lesion. This emphasizes the necessity to characterize the lesions of early pseudo-normalization in the 
early subacute stages. This study observed that reduced MVD and elongated rMTT values were more 
discriminative factors of early pseudo-normalizations lesions at reperfusion day 1 than conventional 
ADC and T2 values, as shown in Figure 4.4 at reperfusion day 1. Interquartile ranges of MVD and rMTT 
in early pseudo-normalization lesion showed the most conspicuous difference compared to those of 
typical pseudo-normalization lesion except for the ADC which interquartile range in early pseudo-
normalization lesion is close to median value of contralateral region. However, in early pseudo-
normalization lesion, CBV and rCBF showed more conspicuous alterations compared to rMTT in 
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Figure 4.4, which required further investigation regarding their association with edema progression. 
Assessing morphological and functional vascular remodeling in both edema lesions up to chronic stage 
could provide more accurate diagnostic and therapeutic information of ischemic stroke.  
To validate MRI-derived microvascular remodeling related to the VSI, MVD, and CBV, 3-
dimensional LSFM images were acquired and analyzed. In the contralateral cortex regions, the MRI- 
and LSFM-derived vessel size (4.2 μm and 4.26 μm, respectively) and vessel density (314.2 mm-2 and 
286.3 mm-2, respectively) quantities were comparable with each other. In addition, the size and density 
values were consistent with previous reports [13,46,66]. The ratios of the MRI-derived vessel size, 
vessel density, and blood volume values between early and typical pseudo-normalization lesions were 
in a comparable range to those of LSFM-derived. However, as the thickness of the LSFM image 
increased, the estimated vessel density was also observed to be increasing. This is directly visible in 
Figure 4.11, as more vessels are included with increasing thickness. Considering that MRI- and LSFM-
derived vessel densities were comparable at 4~6 μm of LSFM images, the results are consistent with a 
previous comparison between the MRI-derived vessel density and corresponding (similar thickness) 
histology results [46,50,106]. Such underestimation of the MRI-derived vessel density with larger 
thickness may be partially understood using a Monte Carlo simulation, as shown in Figure 4.14. A 
simulated MVD was calculated using MRI experimental conditions following previous methods [89]. 
The difference between the true vessel density and simulated MVD increased as the true vessel density 
increased. In contrast, the simulated MVD showed a similar value (linearity) with the true vessel density 
when the true vessel density was under 300 mm-2, as shown in the inset figure of Figure 4.14. Further 
elucidation is required to rigorously verify the correlation with volumetric MRI-derived MVD and other 
validation methods, including 3-dimensional LSFM. 
It is also noteworthy that the acquisition of LSFM images may be affected by the status of tissue 
clearing. Although the contralateral region showed complete tissue clearing status, ipsilateral lesions in 
both tMCAO rat models may not be perfectly cleared due to different tissue conditions than that of the 
contralateral region, which can induce bias for the absolute quantification of the vessel radius, vessel 
density, and blood volume. However, the ratio of vascular parameters appears to maintain close 
resemblance with respect to MRI measurements, which minimizes the clearing issues. In addition, the 
UTE-MRAs and fluorescence stereo zoom microscope image of two tMCAO rat models (without tissue 
clearing) showed an enlarged vessel size and reduced vessel density for early pseudo-normalization 
lesions, which is consistent with tissue-cleared LSFM findings, as shown in Figures 4.5 and 4.12. 
Establishing an optimization method for perfectly clearing ipsilateral ischemic lesions is necessary for 
the absolute quantification of microvascular alterations.  
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In this study, along with the tissue status, morphological and functional vascular remodeling were 
simultaneously visualized and quantitatively analyzed as reperfusion continued from day 1 to 7 (in the 
subacute stage). This enabled verification of contrasting vascular remodeling tendencies between early 
pseudo-normalization and typical pseudo-normalization lesions. Evaluation of both morphological and 
functional vascular remodeling in two spatiotemporally different lesions may help better inform clinical 
decision making on the prognosis and treatment of ischemic stroke in the subacute stage. 
The original source of Chapter 4 is the article, Kang, M.; Jin, S.; Cho, H., MRI investigation of 
vascular remodeling for heterogeneous edema lesions in subacute ischemic stroke rat models: 
Correspondence between cerebral vessel structure and function. Journal of Cerebral Blood Flow & 
Metabolism 2021, (Accepted). 
 
 
















Chapter 5. Concluding remarks 
5.1 Summary 
With the requirement of vascular remodeling assessment, dual contrast MRI enabled simultaneous 
visualization and quantification of whole brain morphological and functional vascular remodeling in 
ischemic edema lesion. Furthermore, vascular remodeling of spatiotemporally different ischemic edema 
lesions was separately investigated and those lesions showed different vascular remodeling tendencies. 
Correlations between morphological and functional vascular remodeling were observed, which could 
be utilized to understand ischemic stroke induced hemodynamics and metabolism alterations. 
Acquisition of various vascular parameters provided further information regarding progression of 
ischemic stroke in addition to conventional measurement of lesion status via ADC and T2.    
 
5.2 Limitations and Future works 
Acquisition of dual contrast MRI for visualization of macro- and microvascular remodeling relies 
on the assumption that blood-pool contrast agent SPION is not extravasated through blood-brain barrier 
(BBB). Severe BBB disruption from cerebral edema could induce leakage of SPION and it may result 
in measurement bias of vascular remodeling. MC simulation was performed in a monotonous vascular 
system. Single vascular size cylinders were randomly generated in a matrix to represent microvessels 
in a tissue. However, various sizes of microvessels are populated in a tissue. Consequently, to perform 
rigorous MC simulation, various sizes of vasculature should be generated in a matrix to represent actual 
microvessel conditions. As dual contrast MRI acquires various vascular parameters, it takes relatively 
long scan time, which hampers its routine application. Regarding long scan time, physiological 
alterations during MR scanning could arise and it may induce translational misunderstanding.  
For future researches, more detailed quantitative analysis of vascular remodeling will be performed. 
As current researches were mainly focused on assessment of vascular remodeling in a subacute phase 
of ischemic stroke, further vascular remodeling researches including not only subacute phase but also 
chronic phase of ischemic stroke is required for rigorous development of biomarker. Extended 
investigation of vascular remodeling will provide further information in aspect of diagnosis and 
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